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\P R E F A C E .
The work on which this thesis is based was carried 
out while I held the post of Medical Registrar in the 
Southern General Hospital, Glasgow. A few of the 
cases were in the wards of Dr. Dick, Visiting 
Psychiatrist, whom I have to thank for his kindness in 
granting me ready access to his cases and records.
The greater bulk of the cases were in the wards of 
Dr. Snodgrass, to whom I cannot sufficiently express 
my gratitude for his help and criticism, and for his 
encouragement when interruptions occasioned by war 
conditions made it seem purposeless to attempt to 
continue with the work. '
Dr. Briggs, then Medical Superintendent of the 
Southern General Hospital, also helped, both by 
granting permission to carry out the work and by his 
interest in the question of diet. A few cases had 
been left on the ordinary hospital diet while certain 
investigations were proceeding. It was thought then
that the ordinary hospital diet was deficient in 
vitamin C. The interest of Dr. Briggs and Dr. Snodgrass 
in/
in this question led to the discovery that the 
ordinary hospital diet was in itself sufficient to 
bring about recovery in certain cases of scurvy. 
Those cases that had not been submitted to full 
investigation before going on this diet had thus 
to be excluded from the series.
Finally, I have to thank Dr. (now Major) 
Chalmers for his criticisms of ny earlier bone 
marrow differential counts; the sisters and nurses 
who took such care to see that the diet that reached 
the patients was that prescribed; Miss Adamson, of 
Killearn Hospital laboratory, who produced adequate 
photomicrograms with apparently inadequate apparatus 
and Messrs. Roche Products who freely supplied pure 
hesperidin.
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NOMENCLATURE
♦•Much of the confusion that mars haematoiogical writ­
ings can be traced to the abuse of terras.** (Scott, 1939). 
On page 8 there is a note on the terminology used in this 
paper, with a list and description (page 11) of the pre­
cursors of the mature leucocyte of the granular series and 
of the mature red cell, when one of the terras in this 
list is used in this paper, it is to be understood that 
the cell to which it applies conforms to this description; 
except that in a few instances, the use of the term is 
that of an author quoted. When this occurs, it is in­
dicated by a statement to that effect, or by the appear­
ance of the passage in quotations over the name of the 
author.
1INTRODUCTION
The purpose of this thesis is to determine to
what extent vitamin C may be regarded as a
substance of importance in the maturation of the
red cell.
*
It was formerly commonly believed that 
vitamin C exercised a specific function in 
erythropoiesis. This view has been held by 
Armentano (1938), Aron (1928), Diblicek and 
Kucera (1938), Hojer (1942), Mettier et al.(l330), 
Mettier and Chew (1938), Mouriquand et al.
(1934, 1938), Parsons (1938), Parsons and Small- 
:wood (1935), Rohmer et al. (1938) and Rohmer 
and Bindschedler (1938). There was difference 
of opinion as to the phase of maturation at 
which the vitamin acted. Mettier et al. (1930) 
and Witts (1932) considered that it acted at the 
phase of maturation from normoblast to erythrocyte 
while Whitby and Britton (1942) represented it 
as/
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2as acting at the phase of maturation from erythro- 
;blast to normoblast. The diagrams opposite 
illustrate these views. (The nomenclature above 
is that of the authors cited). Parsons (1933), 
on the other hand, considered that the vitamin 
acted throughout the whole range of maturation, 
and not at a single phase only.
This work was first planned with a view to 
obtaining information on this question, it being 
accepted as already established that vitamin C was 
a specific erythropoietic factor. As the work. 
progressed, however, instances appeared which were 
difficult to reconcile with this view. “Belief 
in the need for vitamin G has dwindled11 (flcwlillan 
and Inglis, 1944); and it has been suggested that 
the anaemia of scurvy may be due to a lack of 
other factors than vitamin C (Croft, and Snorf,1939).
Briefly, severe deficiency of vitamin C may 
occur without anaemia; so that there is difficulty 
in regarding vitamin C as essential to erythropoiesis. 
But/
But the addition of pure vitamin C to a diet on 
which scurvy and anaemia have developed may as 
efficiently correct the anaemia as remove the 
signs of scurvy; so that it is equally difficult 
not to regard the vitamin as being able to play 
some part in erythropoiesis.
In this thesis an attempt is made further to 
elucidate the role of vitamin C in erythropoiesis.
3UETEODS Off EXAMINATION AND TESTS EMPLOYED.
These fall into three categories: firstly, those 
referring to the state of the case as to the degree of 
vitamin c deficiency; secondly, those referring to the 
haematological condition; and thirdly, a number of tests 
not falling into either of these groups. In the first 
category fall, for example; an account of the diet of 
the subject before coming under observation; the physical 
examination, involving the physical diagnosis of scurvy; 
and chemical methods of estimating the presence or ab­
sence of vitamin 0 deficiency and the degree of such de­
ficiency -when present. In the second.fall the examin­
ation of the blood and bone marrow, in the third are a 
number of diverse tests which were found to be relevant. 
These include gastric analysis, assessment of capillary 
fragility and red cell fragility.
DIET A number of the cases were inmates of a 
mental institution. In these cases the diet could be 
controlled- and records,of the diet of the institution 
and of the patients’ refusal of certain articles of the 
diet, had been kept and could be studied. In the re­
maining cases the diet had been so restricted,either 
voluntarily or because of destitution, that the patients 
easily recollected the limited number of articles that
4it had. contained.
While under investigation, each case remained 
on the diet to which he had'been accustomed.
PR1SIUAL JSAAMIiJATION :- The following features 
when confirmed by the chemical tests, were taken as 
evidence of the presence of scurvy: follicular haemor­
rhages ana ecchymoses, chiefly on the legs; red blood 
cells in the urine; dyspnoea on exertion, of recent on­
set, in the absence of signs of renal inadequacy or of 
organic heart disease. These features were common to 
all the cases considered to be scorbutic, in adaition, 
one o r  more of the following features was usually pre­
sented: sponginess of the gums - this was found in every
case in which the jaws were not edentulous; effusion 
into the knee joints; brawny indurated swelling in the 
thigh or calf muscles; moist sounas in trie lung bases 
and oedema 01 the ankles; and profound weakness.
These features, although severally they might be 
found in a variety of conditions, were collectively 
considered sufficient evidence of the scorbutic state. 
This was supported by the fact that they disappeared 
with antiscorbutic treatment.
5in the non-scorbutio cases none of these signs 
was present, though in some cases there was complaint 
of unusual weakness or of recent onset of dyspnoea on 
exertion.
four of the thirteen cases of scurvy were found 
to be complicated by co-existing disease; namely, 
two cases of duodenal ulceration and two of rheumatoid 
arthritis. The effect of antiscorbutic treatment in 
these cases is not recorded, since the possible co­
existence of anaemia unrelated to vitamin c deficiency 
introduces uncontrollable factors.
ASCOKBIC AC IB BBT'BhMiiMATlUNS: - Three chemical meth­
ods of assessing the ascorbic acid levels were employed. 
These were: Better's test; the estimation of the fast­
ing plasma ascorbic acid level; ana the intravenous 
ascorbic acid tolerance test.
hotter*s Test;- T h i s  was employed in order rapidly 
tc obtain an approximate estimate as to whether or not 
there existed a material degree of vitamin c deficiency. 
The basis of the test is the decolonisation of a solut­
ion of 2:6 dichlorophenol-indophenol, injected intra- 
dermally, by the ascorbic acid in the skin (hotter,1937;
6Portnoy and Wilkinson, 1938a). Absence of vitamin 
C deficiency is indicated by a short decolorisation 
time, and the time is more prolonged the more severe 
the deficiency.
Plasma Ascorbic Acid:- The single estimation 
of the fasting plasma ascorbic acid level has been 
held to give an estimate as to whether or not a de­
ficiency of vitamin C existed, and as to the degree 
of such deficiency, sufficiently accurate for most 
routine purposes (Harris et al., 1936; Portnoy and 
Wilkinson, 1938b; Sloan,1938).
The level was estimated by the original method 
of Farmer and Abt (1935) . In this method the blood 
is deproteinised by orthophosphoric acid solution 
and the protein-free filtrate is titrated against 2:6 - 
dichlorophenol-indophenol, the titration being run 
within half an hour of withdrawal of the blood. The 
modification introduced by Pijoan and Klemperer (1937), 
which was designed to prevent loss of ascorbic acid in 
the specimen through oxidation, was avoided;as Ludden 
and Wright (1940) and Farmer and Abt (1938) had come 
to the conclusion that the modification gave false
7readings and that no appreciable loss of ascorbic acid 
occurred if titrations were run within half an hour of 
withdrawal of the blood.
Intravenous Tolerance Test:- Sloan (1938) shewed 
that the most accurate estimate of the degree of deplet­
ion of vitamin C is given by the rate of absorption from 
the blood stream of an injected dose of the vitamin. 
Harris et al, (1936) found that the response to a test 
dose was proportional to the fasting ascorbic acid level.
The method used in this series was that of Portnoy 
and Wilkinson (1938b) in which the plasma ascorbic acid 
levels are estimated before and at intervals after the 
intravenous injection of a dose of ascorbic acid. In 
states of depletion, no considerable rise after injection 
is obtained, while the level rises to a considerable 
height in the absence of deficiency,
BLOOD BXAMIH AT IONS' i- The following determin­
ations were carried out, using oxalated venous blood:
Haemoglobin (Hb) This was estimated in a Sahli
type haemoglobinoaeter. The results as tabulated repre­
sent the mean of four separate readings. One hundred 
per cent haemoglobin is equivalent to 13.8 milligrammes 
per cent.
8Red Cell Count. (R.B.C.)
Reticulocyte count:- This was made on wet films 
stained by brilliant cresyl blue.
Yfhite Cell Count. (W.B.C.)
Schilling Count:- This is the modification of the 
differential count introduced by Schilling (1929)
The normal haemogram as given by Schilling is as 
follows:
03
rH•H.d
ftOw
d
PQ
Neutrophils
w
H•H
' f t
8
•rl
01O
m
a>
-P
&o
H<D
01ai
rH•Hda>
5
01
ft
tl+3
CO
TJai
clai
I<L>
m
w<D
-p
&a
xs&
w<D
ftoodo
Mean 4 63 23
Range 0-1 --4 0-1 3-5 51-67 21-35 4-8
Basophils, eosinophils, lymphocytes and monocytes are 
so well known as to require no further description.
The other cells will be briefly described when nomen­
clature is discussed (page 11 )•
Cooke count:- This is the cooke modification 
of the Arneth polynuclear count {Cooke and .ponder, 1927) . 
The "weighted mean" indicates the amount of lobulation
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9in the polymorph nucleus. The average is 2.7 j in­
crease may be referred to as "right shift” and decrease 
as "left shift” .
platelet count;- The method used was that of es­
timating the proportion of platelets to red cells in a 
wet film.
BOiMh m ARKum iJLAiuiiMATi0l\i:- The bone marrow was ob­
tained by sternal puncture, using a needle of the Salah 
type. jjilms were made immediately and stained with 
Leishman*s stain. As recommended by yeott (1939) not 
more than u.2 cubic centimetres of marrow were aspir­
ated at a time, since larger amounts tend to give ex­
cessive dilution of marrow with blood.
uellularity;- The nucleated cells in the specimen 
were not enumerated,but following scott's practice, the 
celiularity - i.e., tne number of nucleated cells in a 
microscope field - is recorded as being either low 
j[approximateiy that of a normal blood film; , medium 
(that of the healthy marrow; or high. The photo­
micrographs opposite illustrate these appearances.
Differential uount:- The nomenclature used in 
this paper is that of pcott (1939;, who followed
10
Ferrata (1933), with some modifications that do not 
apply to the present work. The myeloid series
(granuloblast) is divided into myeloblast, promyelo-
)
cyte, and neutrophil granulocyte, the latter being 
further subdivided into the grades originally suggested 
by schilling (1929; of myelocyte, juvenile, staff and 
segmented forms. The orthoplastic (normal; precursors 
of the mature red cell are known collectively as the 
erythroblast, The series consists of pronormoblast, 
and basophilic, polychromatic and orthochromatic normo­
blasts. The table below shows how this nomenclature 
appears to correspond witn other authors1
Scott (1939;. 
Wintrobe. (1942).
: whitbv and : 
Britton. (1942;.
Davidson et 
al (1942).
Pronormoblast : Megaloblast : erythroblast 
Type i
Basophilic
normoblast
: Erythroblast : erythroblast 
Type ii
polychromatic
normoblast
: Late
erythroblast
erythroblast 
Type ill
Orthochromatic
normoblast
: normoblast : erythroblast 
Type IV
11
The term "megaloblast" is reserved for the abnorm­
al cell observed in pernicious anaemia during re-
n
lapse. "Plasma cell" includes both Turck cells 
and bone marrow plasma cells.
The following is a brief description of the 
main features of the cells of the granuloblast and 
of the erythroblast.
Myeloblast:- This is a large cell with a baso­
philic cytoplasm with a deeply staining rim fading 
as the perinuclear zone is approached. The nucleus 
stains palely and contains nucleoli, it presents 
a little condensation of chromatin at the edge and 
round the margins of the nucleoli.
promyelocytes:- The basophilia of the cytoplasm 
is now less intense ana scattered through it are 
coarse violet granules. The nucleus resembles that 
of the myeloblast but the chromatin has undergone a 
little condensation to produce a little less fine 
stippling and the nucleoli have disappeared.
Myelocyte:- The cytoplasm is pale blue to 
neutral, with mature neutrophilic, basophilic or 
eosinophilic granules. The nucleus may be round
\z
or oval, or slightly indented, with coarser and 
darker interstices.
Juveniles:- The cytoplasm may be slightly 
basophilic but is usually neutral and contains 
neutrophilic granules with a tendency to azuro­
philic characterestics.
Staff:- The nucleus is more slender and darker 
than in the juvenile and is often twisted and with 
indentation suggestive of beginning segmentation.
Segmented neutrophil:- The nucleus is divided 
into segments connected in a chain by fine threads. 
The cytoplasm contains mature granules.
pronormoblast:- The cytoplasm is deeply baso­
philic, with a paler perinuclear halo. The nucleus 
is of a fine stippled texture and contains nucleoli.
Basophilic normoblast:- The basophilia of the 
cytoplasm is less intense and the nuclear pattern 
coarser than in the pronormoblast. The nucleus is 
becoming basichromatic and nucleoli have disappeared.
Polychromatic normoblast!- The cytoplasm i s , 
slate-grey and the nuclear chromatin is in coarse 
clumps.
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Orthochromatic Normoblast:- The cytoplasm is ortho- 
chromatic. All trace of structure in the nucleus has 
disappeared and it is intensely basichromatic •
Maturity Dispersal Ratios:- These were calculated 
in order to assess shift in maturity in successive speci­
mens of bone marrow, m  the erythroblast, the proportions 
of pronormoblasts, basophilic normoblasts, and polychrom­
atic and orthochromatic normoblasts together, are calcul­
ated, the figuresbeing given as percentages of the total 
erythroblast. in the granuloblast, the proportions of 
myeloblasts, promyelocytes, myelocytes, and juveniles 
are calculated as percentages of the sum of these four , 
types.
GASTRIC ANALYSIS:- A Refuss fractional test meal 
examination was carried out in each case. When achlor- 
hydria was found, the histamine test meal was performedf 
The fractional test meals were carried out before eonu- 
mencing treatment, in cases 14, 15 and 16, the histamine 
test meal was carried out on the day after commencing 
treatment.
OTHER TESTS:
CAPILLARY FRAGILITY:- This was determined by a 
positive pressure method, similar to that used by
14
Gothlin (1937)• The capillary fragility is given by 
the number of petechiae counted, in a good light and 
with the aid of a hand lens, in a circle of one inoh 
diameter on the volar aspect of the forearm, after a 
pressure of eighty millimetres of mercury has been 
maintained for fifteen minutes in the sphygmomanometer 
©tiff round the arm. By this method, up to ten 
petechiae may be regarded as normal.
In most cases the following additional tests were 
carried out: van den Bergh reaction, the icteric index, 
and the urinary urobilin by Schlessinger's method, in 
the cases of scurvy, fragility of the red cells was 
estimated.
When the expression "before treatment" is used, 
it is to be taken to refer to investigations carried 
out on the case* first coming under observation, be­
fore any antiscorbutic or anti-anaemie treatment was 
earried out; and the expression "after treatment", 
to Investigations carried out after the case had 
reached a state where no evidence of vitamin defic­
iency could be found.
15
QBMJSHAL account of the c a s e s.
The cases are grouped primarily according to the 
presence or absence of anaemia and to the response of 
the anaemia to administration of ascorbic acid. Group 
1 contains those cases in which anaemia was not a feat* 
ure. None of these cases had any sign of scurvy.
Group II contains those cases in which there was anaemia, 
remission in which took place when ascorbic acid was ad­
ministered* scurvy was present in all these cases*
Group 111 contains those in which there was anaemia on 
which ascorbic acid alone had no demonstrable effect*
Both scorbutic and non-scorbutic cases occur in this 
group*
in Group IV there are four cases of scurvy associated 
with anaemia. The effect of treatment is not recorded, 
since the picture was complicated by the presence of pep­
tic ulceration in two cases and of rheumatoid arthritis in 
two others* The cases are included in order that the 
blood and bone marrow pictures here may be compared with 
those of the cases in which there was no apparent com­
plication of the vitamin deficiency*
16
d
Group I. Gases in which no blood 
abnormality was found.
(Cases 1 - 6 .  Tables I to VI,'appendix)
DIET :- These cases were schizophrenic male 
inmates of a mental institution, on a standard hosp­
ital diet. While this diet contained an adequacy 
of fresh fruit and vegetables, the cases in question 
had refused various articles and had had cooked food 
only for at least two years. It was therefore im­
agined that the quantity of vitamin c actually con­
sumed would be very low. No attempt was made to 
estimate the actual amount.
When the examinations were complete, three hun­
dred milligrammes of ascorbic acid were administered 
daily by mouth. In addition one thousand milli­
grammes were injected intravenously at the begin­
ning of treatment, this being required for the carry­
ing out of the ascorbic acid tolerance test.
PHYSICAL EXAMINATION :- Each case appeared to 
be in good general health. They were males of be­
tween forty and fifty years of age. There was no 
evidence of the scorbutic state.
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ASCORBIC ACID DETERMINATIONS 
Rotters Test:- Before treatment, decolor- 
isation times were prolonged. The mean time was 
sixteen minutes, and the range from ten to thirty- 
two minutes. After treatment, normal values were 
given, the mean decolonisation time being four and 
a half minutes. In no case was the time over five 
minutes.
Plasma Ascorbic Acid The level was estimat­
ed on the case first coming under observation, and 
again a month or more later, no ascorbic acid having 
been given in the meantime. There was no signifi­
cant difference between the two estimations, either 
in the cases separately or in the mean values. The 
mean of the first was 0.49 milligrammes per cent, 
and of the second, 0.50 milligrammes per cent. The 
range of values was from 0.42 to 0.58 milligrammes 
per cent. After treatment, a considerable elevat­
ion from these was found, the mean being 1.7 and the 
range from 1.4 to 2.0 milligrammes per cent.
Intravenous Tolerance Test :- This test was 
not carried out on the case first coming under ob­
servation, as it involved injecting a large dose of 
ascorbic acid. This was avoided in order to observe
12
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whether or not any material change took place while 
the patient remained on the diet presumed to be low 
in ascorbic acid. The test was carried out just 
before treatment was begun and again after treatment. 
Tig. I shows the curves obtained. Before treatment, 
the curves are markedly lower and flatter than after 
treatment.
CAPILLARY FRAGILITY The petechial counts
were low both before and after treatment, except in 
case 6 where the moderately high count of ten was 
obtained. This was not affected by treatment. The 
means were five petechiae before and four after treat- 
ment.
BLOOD EXAMINATIONS.:-
Haemoglobin:- The levels were above ninety per 
cent except in one case where one reading of eighty- 
nine per cent was obtained. Treatment with ascorbic
acid produced no demonstrable change. The mean per­
centages were ninety-eight before and ninety-nine 
after treatment.
Red cell Count:- The lowest (case 3) was of 
4.3 million per cubic millimetre.
Treatment with ascorbic acid produced no demon-
19
strable change in the red cell counts.
The colour index lay between 0,9 and 1.1 except 
in case 4 where it was 1.2, The colour index was 
not significantly affected by treatment.
Reticulocyte count:- Reticulocytes were counted 
for three days before and for seven days from the be­
ginning of treatment. No deviation from the normal 
was observed.
White cell Count:- The range, before treatment, 
was from 3,6u0 to 1,000 per cubic millimetre. No 
effect of ascorbic acid treatment on the white cell 
count could be demonstrated. The means were 6,200 
before and 7,200 after treatment.
Schilling count:- No significant deviation from 
the average normal, either before or after treatment 
eould be demonstrated.
Cooke count;- no effect of ascorbic acid could 
be demonstrated. The mean value for the "weighted 
mean" before treatment was 2.7, with a range of 2.5 
to 3.0, and after treatment the mean was 2.6, one 
case (4) only diverging^with a weighted mean of 2.8.
Platelet count:- one count was carried out 
in each case, before treatment. No abnormal values '
were found.
Table 1
Maturity Dispersal Ratios, Group I. Percentages 
before and after treatment, compared with mean 
normals (Scott, 1939)
Before Treatment After
Treat­
ment
cfean
Normal
(Scott)At begin­
ning of con­
trol period
At end of
control
period.
Granuloblast
Myeloblast. 5.5 5.7 5.5 5.1
Promyelocyte 12.9 14.9 13.9 12.6
Myelocyte 36.6 33.4 33.8 37.2
Juvenile 44.9 46.0 46.9 45.0
Erythroblast
Pronormoblast 2.0 1.9 2.6 2.5
Normoblast-basophilic 15.1 16.5 14.9 10.8
Polychromatic
and orthrochrom-
atio 82.9 81.6 81.8 86.6
20
BUlME MARhUW
uellularity; - Medium cellularity was found 
throughout.
differential uount:- no gross or constant ab­
normality was found, and no change after treatment 
could be demonstrated.
Maturity dispersal Ratios;- “fable 1 opposite 
shows tne mean percentage before and after treat­
ment, compared with the means of six normal cases 
given by scott (1939). it is apparent from this 
table that there is no significant deviation from 
the normal before, and no change after treatment 
with ascorbic acid in this group.
UASfitlU AhiLLiSIS:- The free and total hydro­
chloric acid curves of the iractional test meal 
were within normal limits in each case.
OTHEK TESTS:- The van den dergh reaction was 
negative, urinary urobilin could not be demonstrat- 
ea, and icteric index was within normal limits in 
each case. These tests were carried out before 
treatment•was begun.
Zl
Group II. scurvy associated with anaemia;
1
full response to ascorbic acid.
(Cases 7 to 13, tables VII to XIII, appendix)
DIET:- in all the cases in this group, the diet 
had been selected from the following articles; bread, 
biscuits, pastry, margarine, jam, sausage, fish, minced 
meat, pasteurised milk:, tea and sugar, m  no instance 
had any fresh fruit or vegetables been eaten for at 
least six months before the case came under observation.
The cases remained on the same diet during the 
period of observation. As soon as the necessary ex­
aminations had been carried out, ascorbic acid was ad­
ministered, starting with one thousand milligrammes 
intravenously and continuing with three hundred milli­
grammes daily by mouth.
PHYSICAL EXAMINATION:- All the members of this 
group presented signs of scurvy. The ages ranged from
fifty-one to seventy-two years. cases 7, 9 and 10
were aged respectively sixty-eight, sixty-five and 
seventy-two years, and in these cases a certain amount
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of senile cardiovascular degeneration was evident, though 
not to an extent greater than was to be expected at these 
ages. otherwise there was no evidence of organic dis­
ease in this group after the evidence of scurvy had dis­
appeared.
ASCORBIC ACID DETERMINATIONS:-
Rotter*s Test:- Before treatment, the decolonisat­
ion times were prolonged, the shortest time being twenty 
minutes and the mean thirty-five minutes. After treat­
ment, much shorter times were obtained, eight minutes 
being the longest and the mean being six minutes.
jelasma Ascorbic Acid:- Before treatment, low levels 
were obtained, the range being from 0*31 to 0.47 milli­
grammes per cent with a mean of 0.38 milligrammes per 
cent* After treatment, high levels were obtained, the 
range being from 1.3 to 1.9, with a mean of 1.6, milli­
grammes per cent.
intravenous tolerance Test:- The curves obtained 
are shown in figure 11 opposite. The curves obtained 
before are markedly lower and flatter than those obtained 
after treatment.
23
CAPILLARY FRAGILITY-:- High capillary fragility
the
was found in eaeh case,/mean count, before treatment, 
being of sixty-eight petechiae. After treatment, normal 
counts were obtained, the mean being of six petechiae.
BLOOD EXAMINATIONS.
Haemoglobin and Red cell counts;- Every case showed 
some degree of anaemia. The most severe (case 7) had a 
haemoglobin level of forty-two per cent and 1.95 million 
red cells, while the least severe (case lo) had eighty- 
two per cent haemoglobin and 3.b million red cells. Ad­
ministration of ascorbic acid was followed by a rise in 
the red cells and haemoglobin. in five of the seven 
cases in this group, the anaemia was orthochromic; while 
in one (case 11) it was hyperchromie, and in another 
(case 12) hypochromic.
Reticulocytes:- Before treatment, the reticulocyte 
count was above normal, and after institution of treat­
ment, a reticulocyte crisis was observed.
The association of the reticulocyte crisis and the 
rise in red cells and haemoglobin can be seen from the 
blood charts (figures I t o M  , pages lv to Ixi , ap­
pendix) .
Table 2
schilling counts, croup II. Mean counts 
before and after treatment.
Before Treat­ After Treat­
ment ment
Eosinophils' 0*3 per cent 0.7 per cent.
basophils 0.2 " w 0.2 " **
Myelocytes - -
juveniles 0.5 " 1.2 w »
Staffs 1.0 11 " 3.9 " "
Segmented
Neutrophils 43.9 *» » 53.6 w *
Lymphocytes 46.5 " " 33.0 " *
Monocytes 7.6 » » 7.5 V **
White cell c o u n t No abnormality before treatment, 
and no change as a result of treatment, could be demon­
strated, the mean counts before and after treatment 
being respectively 5,100 and 5,600 per cubic millimetre.
Schilling count:- in table 2 opposite, the mean 
counts before and after treatment are compared. Relat­
ively, the schilling count before treatment appears to 
show some decrease in juveniles and staffs and increase 
in lymphocytes.
pools Count: - A right shift was observed before 
treatment, the "weighted mean" being 3.2. This mcved 
to the left with administration of ascorbic acid, the 
average after treatment being 2.7.
Platelets:- A count was made before treatment only. 
Normal values were found.
BONE MARROW:-
Cellularity:- Before treatment there was increased 
cellularity. and medium cellularity was found after treat­
ment.
Differential count:- in both the granuioblast and 
the erythroblast, certain changes were noted which are 
referred to under the heading "Maturity Dispersal Ratios" 
below. No abnormal types of cell were observed.
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Megakaryocytes could be found in every specimen, though 
in some cases search had to be made in several films , 
while in others they were of more frequent occurrence. 
Mitotic forms of the normoblast were more commonly found 
during the phase of active scurvy, i.e. before treatment, 
than after treatment, the means being 1.3 per cent (of 
all the nucleated cells in the differential count) before 
treatment, and 0.2 per cent after treatment, it could not
be clearly shown that there was any increase in the number
of mitotic forms after beginning treatment, m  cases 11,
12 and 13, bone marrow films were made at the time of the
reticulocyte crisis that followed ascorbic acid adminis­
tration. The mitotic forms were then 1.2, 2.0 and 2.0 
per cent respectively for the three cases, as compared 
with 0.4, 1.2 and 1.6 per cent before treatment. This 
apparent slight increase after the institution of treat­
ment cannot be regarded as significant, in view of the 
variability of the numbers of mitotic forms, the mean 
percentage before treatment- of 1.3, with a standard de­
viation of o«7 giving an indication of this variability.
Table 3
Maturity Dispersal patios, Group II# Mean 
percentages before and after treatment#
Before Treat­
ment
After Treat­
ment
Myeloblasts 5.1 per cent 4.7 per cent
promyelocytes 22.0 t t 13.2 tt tt
Myelocytes 37.4 tt tt 36.5 tt »
Juveniles 35.5 tt t» 45.6 n t»
pronormoblast 3.3 tt tt 1.5 tt tt
Normoblast
Basophilic 46.0 It tt 15.8 tt n
Polychromatic
and orthochrom-
atic 50.7 tt tt 62.7 tt tt
£6 -
Maturity Dispersal Katioss- Table £ opposite 
shows the mean dispersions before and after treatment, 
in both granuloblast and erythroblast, there is a shift 
towards a * relatively greater immaturity in the marrow 
from cases of active untreated scurvy, m  the granulo­
blast, the promyelocytes showed an increase and the juv­
eniles a decrease, relatively to the percentages found 
after treatment, m  the erythroblast,.before treatment 
there was a considerable increase in the basophilic normo­
blasts and a corresponding decrease in the polychromatic 
and orthochromatic forms, relatively to percentages found 
after treatment.
OASTRIC ANALYSIS:- The free and total hydrochloric 
acid curves were within normal limits in each case.
OTHER TESTS:- There was no evidence of increased 
haemolysis in the cases of untreated scurvy, to the ex­
tent that the van den Bergh reaction and the test for 
urinary urobilin were negative, and the icteric index 
was within normal limits, jrragility of the red cells was 
within normal limits.
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Group ill* Vitamin c deficiency associated
with anaemia; poor or no response 
to ascorbic acid.
(Cases 14 to 17, tables jlIV to XVII, appendix) 
DIET:- This was similar to that of the cases 
in the preceding group.
in case 14, iron deficiency being suspected, iron 
was administered;then, as it had had no apparent effect 
on the anaemia or reticulocyte counts, it was discontin 
ued and ascorbic acid and oranges added to the diet, as 
corbic acid deficiency having been shown to be present; 
these, and also an intramuscular injection of liver ex­
tract ("Anahaemin") having been equally without effect, 
iron was again administered, in the same dosage as on 
the first occasion; a reticulocyte response and a rise 
in the red cells and haemoglobin now followed.
in cases 15 and 16, treatment with ascorbic acid 
having had no apparent effect on the anaemia, four or­
anges daily were added to the diet, as well as the as­
corbic acid; whereupon a reticulocyte crisis and a
Z9
rise in the red cells and haemoglobin were obtained.
in case 17, hesperidin was given by intravenous 
injection for a week, during which the anaemia became 
more severe. The hesperidin was then discontinued 
and ascorbic acid administered, but the anaemia failed 
to improve. Ascorbic acid and hesperidin were then 
administered concurrently, when a reticulocyte erisis, 
followed by a rise in the red cells and haemoglobin, 
was obtained.
PHYSICAL EXAMINATION:- There was no sign of 
scurvy in cases 14 and 15, but scurvy was present 
in cases 16 and 17. case 15 was a very senile indiv­
idual of seventy-eight years, bedridden and mildly de­
mented. There was no material change in this general 
condition after administration of vitamin c. Case 16, 
aged seventy-one years, was much less senile and had 
been accustomed to take a walk of about five miles al­
most daily, until six months before coming under obser­
vation when he began to experience dyspnoea on exertion, 
which steadily increased, on admission to hospital he 
had a moderate degree of congestive heart failure, with 
no evidence of valvular disease or hypertension, and
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an electrocardiogram showing no diagnostic abnormal­
ity. No treatment of his cardiac condition was 
carried out, other than rest in bed for a month, and 
antiscorbutic treatment. He recovered to the extent 
of being able to resume his walks. it was considered 
that the vitamin u deficiency was the main factor 
in bringing about the cardiac failure, since it had 
responded so completely to a short period of rest 
with administration of the vitamin.
ASCORBIC ACID DETERMINATIONS:-
Rotter*s Test:- Before treatment, decoloris- 
ation times were prolonged, the shortest time being 
twenty minutes, and the mean twenty-five. After 
treatment a marked drop was noted, the longest time 
then being six minutes and the mean five and a half 
minutes.
Hlasma Ascorbic Acid:- Before treatment, the 
mean level was u.41 milligrammes per cent, the range 
being from 0.35 to o.43 milligrammes per cent. After 
treatment the mean level was 1.4 milligrammes per cent, 
and the range from 1.3 to 1.6 milligrammes,
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intravenous Tolerance Test:- Figu r e s h o w s  the 
curves obtained, those before treatment being markedly 
lower and flatter than those after treatment.
CAPILLARY FRAGILITY:- High petechial counts 
were found before treatment in each case, the mean 
count being of fifty petechiae. After treatment, 
the mean count was of seven petechiae. m  cases 14,
15 and 16 the counts remained high in spite of ascorbic 
acid administration but fell when oranges were added 
to the diet (figures nau to xi ,pageslxii to Ixv , appendix). 
In case 17 the petechial count fell to normal when hes­
peridin was added, appeared to rise slightly when hes­
peridin was withdrawn and ascorbic acid administered, 
and again fell when hesperidin was once more administer­
ed (figure XI , page Ixv , appendix) •
BLOOD iOAMlNATIONS:-
Haemoglobin and Red cell counts:- Anaemia was 
present in all four cases. The percentage haemoglobin 
ranged from fifty-three to sixty-eight, and the red 
cell counts from 1.9*to 3.8 million per cubic milli­
metre. Ascorbic acid alone could not be shown to
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have any effect on the anaemia, but In cases 15 and 
16 improvement appeared to take place from the time 
that oranges were added to the diet, m  case 17, 
Improvement occurred when ascorbic acid and hesperid­
in were given concurrently, though separately they 
hqd had no effect on the anaemia, in case 14 it be­
gan to improve when iron was administered after the 
plasma ascorbic acid level had been raised and the 
Rotter's test decolorisation time brought down by ad­
ministration of ascorbic acid and oranges, although 
the same dosage of iron had had no apparent effect 
before the vitamin u deficiency had been corrected. 
These changes are illustrated in the blood charts 
(figures V0I to , pages W* tol*v , appendix;.
netioulocytes:- The reticulocyte count was some­
what raised before treatment, but appeared to be un­
affected by the addition to the diet of pure ascorbic 
acid only. in case 14, neither iron, nor ascorbic 
acid and oranges, nor liver extract had any effect by 
thmaselves, but a reticulocyte crisis took place when 
iron was administered together with ascorbic acid and
Table 4
Schilling counts, Group III; mean counts 
before and after treatment.
Before treat­
ment .
After treat- 
men t.
Basophils 0.9 per cent 1.3 per cent
Eosinophils 0.3 tt tt 1.0 tt tt
Myelocytes - -
Juveniles 0.3 tt tt 0.9 tt »t
Staffs 1.3 tt tt 2.8 tt tt
Segmented
Neutrophils 50.8 tt tt 51.0 tt tt
Lymphocytes 38.7 n tt 37.3 tt tt
Monocytes 7.8 tt tt 5.8 tt tt
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oranges, after the vitamin deficiency had been at
s
least partly corrected. in cases 15 and 16, a 
crisis occurred when oranges were added to the diet, 
in case 17 no significant change in the reticulocyte 
count could be shown when ascorbic acid and hesper­
idin were separately administered, but a crisis took 
place when these were administered concurrently.
rthite Cell Count:- wo effect of vitamin c admin­
istration on the white cell count could be demonstrated. 
Before treatment the counts ranged from 2,4o0 to 7,400 
per cubic millimetre, with a mean of 4,6o0; and after
treatment, from 4,4o0 to 6,uQ0, with a mean of 5,300.
4
schilling uount: fable/opposite gives the mean
counts, before and after treatment, it can be seen 
that there is no significant change, in this group, 
as a result of treatment.
Cooke uount:- Before treatment, right shift 
was observed, the average "weighted mean" being 3.3.
It fell with treatment, the average after treatment 
being 2.6.
Platelets:- oounts were made before treatment 
only, wormal values were found.
BONE MARBQW:-
cellularlty:- Before treatment, there was increas­
ed cellularity in cases 14, 16 and 17, and medium cellul­
arity in case 15. After treatment, medium cellularity 
was found in 14, 16 and 17, and reduced cellularity in 
15.
Blfierential uount:- In case 14 a film was made 
before treatment, another after the ascorbic acid level 
had risen following administration of the vitamin but be­
fore the anaemia had begun to improve under iron therapy, 
and a third after considerable improvement had taken 
place under iron and vitamin c. In the first two of 
these, there were large numbers of small normoblasts 
with a densely staining nucleus showing no structural 
details, and a slaty-grey cytoplasm with a ragged irreg­
ular outline. These appearances are said to indicate 
iron deficiency (Scott, 1939). In other respects these 
films, and those from the other cases in this group, 
showed no features by which they could have been dis­
tinguished from films from the preceeding group, in 
case 15, the number of mitotic forms of the normoblast 
appeared to be higher before than after treatment, in
Cable 5
Mfttmrtty Bteperaal aatias, C£cemp HI. Mean per­
centages before end after treatment.
Before treat­
ment.
After treat- I 
ment. |
igrelobleete 7.8 per cent 3.2 per cent
Promyelocytes 22.0 " w 18.8 n n
myelocytes 38.0 * m 35.7 n n
Juveniles 32.2 w m 42.4 n *»
Pronormoblasts 3.7 per cent 3.2 per cent
normoblasts
Basophilic 41.3 * *» 17.5 ft 9
polychromatic
crtftoch r**m—
atle 53.0 " » 79.4 n n
The remaining cases there was no significant change 
in the percentage of mitotic forms before and after 
treatment.
Maturity Dispersal .Ratios:- Table 5 opposite 
shows the mean percentage before and after treatment.
In the granuloblast there appears to be a slight in­
crease in the myeloblasts and promyelocytes before 
treatment, relatively to the percentages found after 
treatment. The findings are similar to those in 
group II (page 26). in the erythroblast there is 
no indication of any disturbance of the pronormoblast,
“V
but as in group il the proportion of basophilic normo­
blasts can be seen to be much higher before than after 
treatment.
UASTKIO ANALYSIS:- The fractional test meal showed 
achlorhydrin to be present in each case. A small sec­
retion of hydrochloric•acid was obtained in response to 
histamine.
uTHEK TESTS:- The van den Bergh reaction, the icter­
ic inaex and the test for urinary urobilin, gave normal
results, fragility of the red cells was estimated in 
case 17 only, and was within normal limits.
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Group IV* Sourvy associated with anaemia and 
a disorder not directly referable 
to vitamin C deficiency; effect of 
treatment not recorded.
(Gases lb to 21, tables aVIII ana a Ia , appenaix)
in this group, the effect of antiscorbutic treat­
ment is not recorded because of the association of other 
conditions, themselves associated with anaemia and re­
quiring treatment such that it would have been impossible 
to determine to what extent any observed change was to 
be attributed to the antiscorbutic treatment, and what 
to the treatment of the other condition.
DIET:- The diet of these cases resembled that of 
the preceding two groups.
PHYSICAL examinations- in cases 18 and 19 there 
were signs of rheumatoid arthritis of long standing.
In cases 20 and 21 a history suggestive of duodenal 
ulceration with blood loss of a fairly severe degree, 
was obtained and the diagnosis radiologicaliy confirmed. 
There were signs of scurvy in each case.
ASCORBIC ACID DETERMINATIONS:-
Rotter's Test:- Very prolonged decolorisation times 
were obtained, the mean time being twenty-eight minutes.
Plasma Ascorbic Acid;- The range of levels was from 
0.3 to 0.4 milligrammes per cent, the mean being 0.34 
milligrammes per cent.
intravenous Tolerance Test;- This was not carried 
out on these cases.
CAPILLARY FRAGILITY:- In the two cases of rheumatoid 
arthritis (cases 18 and 19) this was high, but in the two 
of peptic ulceration (cases 2o and 21) the capillary 
fragility was not above normal limits.
BLOOD EXAMINATIONS:-
Haemoglobin and Red cell Count:- There was a moder­
ate degree of anaemia in each case, haemoglobin values 
lying between sixty and sixty-five per cent, in one of 
the cases of rheumatoid arthritis (case 19) the anaemia 
was of the orthochromic type, in the three remaining 
cases it was hypochromic.
White Cell uount;- The white cell counts were 
within normal limits, the mean being 7,200 per cubic 
millimetre.
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Schilling count:- No definite shift could be 
made out•
Gooke count:- There was a shift to the right, 
with a "weighted mean" of 3.2.
platelet count:- The platelet counts were within 
normal limits.
BONN m ARrQW
Cellularity:- There was medium cellularity in case 
18. it was raised in the other cases.
Differential Count;- The small normoblasts with 
slaty-grey cytoplasm and dense nucleus, noted already 
in case 14 (page 33 ) and regarded as indicative of iron 
deficiency, were found more commonly in this group than 
in any of the others and were of frequent occurrence in 
cases 20 and 21. No other abnormality was noted, ex­
cept that recorded below.
Maturity Dispersal Ratios:- In the granuloblast, 
no significant deviation from the normal was observed.
In the erythroblast, there was a definite increase in 
the basophilic normoblasts.
GASTRIC ANALYSIS:- Achlorhydria to the Refuss meal, 
with some response to histamine, was found in the cases 
of rheumatoid arthritis, and hyperchlorhydria was found 
in the cases of duodenal ulceration.
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ANALYSIS AND CORRELATION OF RESULTS
Certain features in the foregoing have now to re­
ceive some elaboration and a number of relationships have 
to be made out.
ASCORBIC ACID DETERMINATIONS
Rotter*s Test:- According to Rotter (1937, 1938) 
a decolonisation time of five minutes or less indicates 
a state of adequate vitamin C nutrition, while more than 
ten minutes indicates a state of "desaturation". The mean 
decolonisation time after treatment, in this series, was , 
five minutes, with a standard deviation (S.D.) of 1.5.
The mean decolonisation time before treatment in group 
1 was sixteen minutes (S.D. « 7.2), and in groups II and 
III together, twenty-eight minutes (S.D. -6.8)• Thus a 
deficiency in each group is indicated, but this is less 
severe in group I than in groups II and III. A defin­
ite improvement was effected by treatment in all cases.
Plasma Ascorbic Acid: The normal values are given
by Abt and Farmer (1938) as from 0.7 to 1.5 milligrammes 
per hundred cubic centimetres of plasma. Portnoy and 
Wilkinson (1938b) give 0.60 to 1.85 milligrammes, van 
Eekelen (1937) considered that a level of 0.4 to 0.8 
milligrammes indicated a moderate, 0.8 to 1.2 a very 
good and above 1.2 an excellent state of nutrition as
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to vitamin C. Sloan (1938) found the lower limit of the 
normal to be 0.5 milligrammes, the average normal being 
between 0.8 and 1.0. In scurvy, Ingalls (1937) found 
the levels to be from nil to 0.15 milligrammes. Wortis 
et al. (1938) found the range to be from 0.22 to 0.3 
milligrammes. Abt and Farmer (1938) found levels of 
0.4 to 0.5 in scurvy. They thought it possible that the 
very low values recorded by Ingalls might be attributed 
to the fact that in his cases potassium cyanide was added 
to the blood sample, after which it was allowed to stand, 
whereas they had shown (Farmer and Abt, 1938) that the 
addition of potassium cyanide did not delay destruction 
of ascorbic acid in the blood sample.
In view of the fact that different authors have 
given such different ranges of value$„it seemed most 
reasonable to accept the standards of Abt and Farmer 
(1938), since it was their method of estimating the 
ascorbic acid level (Farmer and Abt, 1935) that was 
used in this study. According to these standards, 
the ascorbic acid level before treatment in group 1 
of this series was about the upper limit of the scor­
butic range, with a mean level of 0.49 milligrammes
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(S.D. 9 0*05). in groups II and III the mean level was 
lower, being 0*39 milligrammes (S.D. • 0*04)• The high­
est level found was of 0.45 milligrammes, which is within 
the scorbutic range, whereas in group I, the level in case 
4 was above and in cases I and 5 at the upper limit of the 
scorbutic range. After treatment, the mean level of the 
series was 1*6 milligrammes per cent (S.D. * 0.23), and 
the lowest level obtained was of 1.2 milligrammes.
By the standards accepted, therefore, the plasma 
asoorbic acid levels were sufficiently low to confirm 
the diagnosis of scurvy where that had been made on 
clinical grounds. The levels were equally low in four 
cases (2, 6, 14 and 15) in which no clinical sign of 
scurvy was noted, in those cases (1,3,4 and 5) where 
the levels were somewhat higher than in those manifestly 
scorbutic, they were nevertheless still very low. After 
treatment, in all cases, the levels were found to have 
risen to normal.
Intravenous Tolerance Test;- Abt (1937) described 
an oral ascorbic acid tolerance test, in which in scurvy 
the plasma ascorbic acid level rose only slightly after 
administration of the test dose of ascorbic acid, while
Table 6
Intravenous Tolerance Test. Mean values in 
milligrammes ascorbic acid per hundred cubic centi- 
metres of plasma; from present series and from 
Portnoy and Wilkinson (1938b)
-pC to 
© ©  tO *H
CO
Group I
before treatment
Groups II & III 
before treatment
All cases, 
after treatment
Before 
inject­
ion of 
ascorb­
ic 
acid
Pasting
Level
0.49
0.39
1.6
After injection 
Of
ascorbic acid
15
minutes
5.37
2.90
10.27
1
hour
2.06
1.09
6.89
tM
r-»
•H 00 &Cvt o
• c
°e a01
Resting
Level
18
minutes
1
hour
Deficient Group 0.36 4.45 1.69
Hormal Group 1.20 10.12 5.62
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during recovery from the scurvy the peaks after the 
test dose became higher as recovery proceeded* Portnoy 
and Wilkinson (1938b; described the intravenous tolerance 
test, which with slight modification was used in this 
series. Table 6 opposite shows the figures obtained 
by portnoy and Wilkinson 11938b), in a group of subjects 
whose diet had been deficient in vitamin c,  and in a 
normal group; their figures are shown alongside those ob­
tained in the present series. It can be seen that the 
levels in group I of this series, before treatment, are 
somewhat higher, while those in groups II and III are 
somewhat lower, than those in Portnoy and Wilkinson’s 
"deficient group"; and that all these are definitely 
lower than in their "normal group". The levels in 
their normal group corresponds closely with those ob­
tained after treatment in the present series. The 
graphs of the tolerance test (figures 10 , 11 and 12 , 
facing pages 18 ,22 and3o) show the differences be­
tween the curves obtained before and after treatment, 
in cases 5 and 6 (figure lo ) and 14 and 15 (figured ) 
in which there was no sign of scurvy, the curves ob­
tained before treatment were as low as some of those
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found in manifest scurvy.
This test shows that a severe degree of vitamin c 
deficiency was present in every case and that the defic­
iency disappeared with treatment. In group I, the de-
i
ficiency was, generally speaking, less severe than in 
the other groups.
Taking the results of Hotter1s test, the plasma 
ascorbic acid levels, and the tolerance test together, 
it may be concluded that a severe degree of vitamin C 
deficiency existed in every case, in general, however, 
it was less severe in those in which there was no anaemia 
than in the others. In only two of tne nan-anaemic 
cases (5 and 6) v;as tne a eliciency fully as great as 
that seen in the cases of scurvy. Hven in these, the 
tests employed seemed to indicate that the deficiency 
was towards the upper limit, of tne scorbutic range.
The finding of two cases in which there was no 
scurvy and no anaemia, with ascorbic acid values as 
low as tnose found in some cases of scurvy, might be 
taken as suggesting tha-t ascorbic acia deficiency alone 
is not sufiicient to bring about anaemia.
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On the other hand, the ascorbic acid values in these 
two cases being higher than those in most of the cases 
in which anaemia was found may indicate merely that the 
deficiency in these non-anaemie cases was not sufficient­
ly severe to bring about anaemia, For want of sufficient 
data this question must be left unsettled at present.
OAPILLAEGT FRAGILITY:- This test has been regarded 
as one that gave evidence as to the state of nutrition 
as to vitamin 0. Thus Gothlin (1937) and Sloan (1938) 
have stated it as their opinion that the test gave val­
uable information as to whether or not a severe state 
of vitamin c deficiency existed;, and Bourne (1938) in 
cases of gastric ulcer, found lowered capillary resist­
ance which he believed to be traceable to deficiency 
of antiscorbutic vitamins in the diet. Bell et al.(194o) 
found that high capillary fragility was related to low 
ascorbic acid values. However, in a quarter of their 
cases, the high capillary fragility was not affected by 
the administration of ascorbic acid. in a further com­
munication (Munro et al., 1942) they indicated the pos­
sibility that there may be no close relationship between 
#  SuiaiiE rp on page 49
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vitamin C and capillary fragility. Greene (1934), 
Molitch (1935) and Abt et al. (1936) found that tests 
of capillary fragility could not necessarily be related 
to states of vitamin c deficiency.
While pure ascorbic acid given by mouth had been 
found to be an efficient antiscorbutic agent (Svens- 
gaard, 1934; Bell, 1935; Bchultzer, 1938), occasion­
al failures occurred (Elmby and Warburg, 1937; Lauber 
and Bersin, 1939). szent-Gyorgyi and his co-workers 
(Bentsath et al., 1936) introduced "Vitamin bw as a 
factor regulating capillary fragility, reporting that 
"citrin", a mixture of hesperidin and an eriodyctiol 
glucoside (Bruckner and Szent-Gyorgyi, 1936) would re­
duce the number of haemorrhages. They thought that 
deficiency of vitamin B might be partly responsible 
for the haemorrhages of scurvy. croft and snorf (1939) 
found, in man, ascorbic acid values as low as those 
found in scurvy, yet scurvy was not present. They 
thought that this indicated that some factor other ' 
than ascorbic acid deficiency was involved in the 
aetiology of scurvy. Elmby and warburg (1937) found
that to effect a cure in some of a series of cases 
with haemorrhagic diatheses and low ascorbic acid 
values, it was necessary to give orange juice, ascorb­
ic acid alone, by mouth or by injection, having failed 
to effect a cure though it had done so in other cases 
in the series. Histories of gastrointestinal disease 
of long standing were obtained from the cases which had 
failed to respond to ascorbic acid. They though that 
a co-vitamin, perhaps r, might be necessary for vitamin o 
to exercise its effect. ±n a case of scurvy described 
by i^auber and sersin (1939) ascorbic acid failed to effect 
any improvement either in the scurvy or in the accompany­
ing anaemia until a blood transfusion had been given.
Thus there is support for the view that ascorbic 
acid deficiency alone is not responsible for the full 
scorbutic picture. un the other hand, szent-Gyorgyi 
(1938) was unable to repeat his original experiments 
with citrin, and zilva (1937) and moII (1937j also 
had been unable to confirm szent-Gyorgyi’s origin­
al work. Scarborough and stewart (1938j however, 
found that hesperidin, one of the substances pre­
sent in citrin, could reduce the number of skin
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haemorrhages in patients with vitamin deficiencies, 
and that the effect was apparently independent of 
vitamin u. Scarborough (1939; showed that oranges 
and lemons contained a substance which could in­
crease capillary resistance even when ascorbic acid 
had failed to do so. jersild (1939; found that in 
certain cases citrin could increase capillary resist­
ance, the effect being apparently independent of as­
corbic acid. Gorrie (1940) obtained similar effects 
from the use of hesperidin. Scarborough (194u) found 
that the subcutaneous haemorrhages of scurvy were 
corrected by ascorbic acid, but that it did not affect 
the capillary fragility, which was improved by vitamin 
h. he regarded it as established that “there is a 
substance or substances present in fruits and their 
juices and in certain extracts made therefrom which 
is capable in man of increasing the resistance of 
capillary walls to the application of pressure. The 
substance is not ascorbic acid ■* (Scarborough, 1942; .
Armentano (1938; found that citrin had no effect 
on the anaemia of scorbutic guinea pigs, and Scar­
borough (194o) found that hesperidin had no effect
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on the anaemia of human scurvy, crandon et al.
(1941) reported on a case of experimental human 
scurvy, in which the capillary fragility was not 
raised and in which anaemia failed to develop. 
i*ox et al. (194o) had not found increase in the 
capillary fragility in a number of hantu Labourers 
who developed scurvy, it was suggested, however, 
that hantus might not be comparable with Europeans 
in respect of capillary fragility.
m  the present series, normal capillary frag­
ility was found in the cases in group i. m  group 
11 and in, it was considerably raised, m  the 
seven cases in group II, it fell to normal with the 
administration of ascorbic acid, m  three cases in 
group ill (cases 14, 15 and 16j it remained high des­
pite the administration of ascorbic acid, but fell to 
normal when oranges were added to the diet. in case 
17, it fell to normal with the administration of hes­
peridin, rose slightly when hesperidin was discontin­
ued and ascorbic acid administered, and fell to normal 
again when hesperidin and ascorbic acid were administered
concurrently* These changes are indicated in the 
blood charts (figures YE to 3(1 , pages to Iw , 
appendix; • in groups i and ii there was no clinical 
evidence of gastrointestinal disease and normal amounts 
of free hydrochloric acid were found in the test meal, 
m  group i n  however, in which the high capillary
t
fragility was apparently unafrected by ascorbic acid, 
achlorhydriawas present in each case.
Low capillary fragility in scurvy has been re­
corded by Lazarus (Munro et al., 194S) and crandon
et al.(1941). it was observed in two cases (18 and
\
19) in the present study.
in group ll of the present series, the capillary 
fragility, high before treatment, came down while as­
corbic acid was being administered. in group III, 
in cases 14, 15 and 16, the capillary fragility re­
mained high while ascorbic acid was being administer­
ed, but fell on oranges being added to the diet. The 
response of the capillary fragility to hesperidin and 
to ascorbic acid in case 17 has already been noted 
(page5©)# in all the cases of anaemia, the red cell 
count and haemoglobin level rose in association with
the fall in capillary fragility, except in eases 14 
and 17. in the first of these, iron deficiency is 
considered to have been a factor in preventing im­
provement in the anaemia (page 31 ) while in the se­
cond, the rise in red cells and haemoglobin took place 
when the high capillary fragility and low ascorbic acid 
values were simultaneously corrected, although there had 
been no such rise when an attempt was made to correct 
these errors separately (page)t) .
The findings as to capillary fragility and the ef­
fect of treatment thereon, and the relationship of these 
to the anaemia, may now be summarised:
1. Normal capillary fragility was found in two 
cases of scurvy, although in most cases of scurvy 
the capillary fragility was high.
2. in one case of scurvy, hesperidin reduced the 
high capillary fragility, independently of ascorbic 
acid.
‘3, Ascorbic acid restored to nomal the high cap­
illary fragility in seven cases of scurvy, but 
failed to do so in two cases of scurvy and in two 
cases of severe ascorbic acid deficiency without 
scurvy.
4I
4« Achlorhydria was present in each of the
t
four cases in which ascorbic acid failed to restore 
the high capillarry fragility to normal, in three 
of these cases the high capillary fragility fell 
to normal on the addition of oranges, and in the re­
maining case, of hesperidin.
5. in aeven cases of scurvy, a reticulocyte crisis 
followed by a rise in the red cell count and haemo­
globin level were obtained by the administration of 
pure ascorbic acid, but ascorbic acid was ineffect­
ive in two cases of scurvy, in one of which the ad­
dition of oranges had the desired effect; in the 
other, neither ascorbic acid nor hesperidin sep­
arately had any effect, but they were effective 
when administered together. in one case of severe 
ascorbic acid deficiency without clinical scurvy, 
ascorbic acid had no effect on the anaemia but the 
addition of oranges was effective.
This summary may be compared with the follow­
ing, compiled from the literature referred to on pages 4*3 
to 4§ .
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1. Capillary fragility in scurvy is often high 
hut is sometimes normal.
2. Vitamin P may cure the raised capillary frag­
ility of scurvy, this effect being apparently in­
dependent of ascorbic acid.
3. In most cases, ascorbic acid effects a cure in 
scurvy, occasionally it fails to do so.
4. This failure has been noted in some cases to 
be associated with an unhealthy state of the ali­
mentary tract, in such cases, a factor, not ascor­
bic acid but present in lemon juice, is also neces­
sary to effect a cure.
5. Usually, ascorbic acid will cure the anaemia 
of scurvy. Vitamin p has no such effect.
Prom a comparison of these two summaries it 
can be seen that there are reasonable grounds for ac­
cepting vitamint as giving a plausible explanation of 
the fact that ascorbic acid was an effective anti- 
anaemic substance in certain cases of vitamin e deficiency, 
while in other cases of vitamin u deficiency, in which 
there was apparently no significant difference from the
5Z
first as to the blood and bone-marrow pictures, it was 
ineffective* If vitamin P is a necessary co-vitamin 
with vitamin c and if additional amounts of vitamin P 
must be provided in certain unhealthy states of the 
gastrointestinal tract, the failure of ascorbic acid in 
group ill, until some substance that lowered the cap­
illary fragility was administered, would be explained*
in some cases of scurvy, faulty absorption of as­
corbic acid may be a factor in the failure to respond 
to oral ascorbic acid therapy (Hagman, 1937;• Alt et 
al* (1937; showed that there was a tendency for ascor­
bic acid to be low in achlorhydric patients, and Stepp 
(1937; and ilendall and Chinn (1938) showed that certain 
bacteria from the stomach and gastrointestinal tract can 
destroy ascorbic acid, faulty absorption, however, is 
not likely to be a factor in the failure of some cases 
in the present series to respond to ascorbic acid, since 
those cases which showed such failure to respond had re­
ceived an intravenous injection of one thousand milli­
grammes of ascorbic acid, on the occasion of carrying 
out the intravenous tolerance test. This dose is from 
a quarter to a sixth of the total amount required to sat­
urate the case of experimental adult scurvy reported by
5*3
Crandon et al. 11941). schultzer (1937) found that 
forty milligrammes of ascorbic acid daily was an a de­
quate curative dose in scurvy. Also, Goettsch (1935)
has shown that a single massive dose permits the healing 
of scurvy as effectively as the same amount of vitamin 
in divided doses. If failure of absorption of ingested 
ascorbic acid had been alone responsible for the absence 
of response to ascorbic acid therapy in the cases in 
group III of this series, the intravenous dose might 
have been expected to produce sojae improvement, and no 
such response was obtained.
BLOOD EXAMINAT ION: -
Haemoglobin and ned cell Couht:- it appears from 
the varying accounts in the literature that hypochromic, 
orthochromic and hyperchromic types of anaemia can all 
be found in scurvy. Biney (1932) and Turnbull (1936) 
stated that the anaemia was hypochromic. Boyd (>1938) 
stated that it was "secondary", ana described the blood 
picture in secondary anaemia as being of the hypochromic 
microcytic type. Gulland and Goodall (1925), Still (1934) 
and Hutchison (1937) also stated that the anaemia .was of 
the "secondary" type. Dunlop and Scarborough (1938) and 
Whitby and Britton (1942b) stated that a hypochromic
* 4-
or normochromic anaemia was usual, though not constant* 
Bondurant (1934) and ^arsons and Smallwood (1934) said 
that the anaemia was usually orthochromic. oases of ' 
hypochromic anaemia have been described by oomrie (1920), 
Giehner and sherry (1930* and xoung (1938); of ortho- 
chromic anaemia, by uichner and sherry (1930), wood 
(1936), Archer and oraham (1936), jennings and ulaze- 
brook (1938) and ounlop and Scarborough (1938); of 
hyperchromic anaemia, by i\tisenson and uohen (1937) and 
jennings and ulazebrook (1938). parsons (1938) stated 
that he found cases of hypochromic, orthochromic and 
hyperchromic anaemia in scurvy, as to cell size, the 
anaemia is said usually to be normocytic, though it 
may occasionally be macrocytic (Whitby and Britton,
1942; rarsons, 1938; parsons and Smallwood, 1935)•
m  the present series, anaemia was found in all the 
cases or scurvy. m  seven cases, the anaemia was ortho­
chromic (i.e. with a colour index of between u.9 and 1.1): 
in *two it was hyperchromic, and in one hypochromic. m  
each case the anaemia is considered to be definitely 
related to scurvy, since great improvement took place
o i l  the addition to the diet of ascorbic acid, in some 
cases with the addition of oranges or hesperidin, the 
diet being in other respects Identical with that on which 
scurvy had appeared* in two cases in which there were 
no clinical signs of scurvy but in which ascorbic acid 
values as low as those of scurvy were found, anaemia was 
present. In one of these it was hyperchromic, and res­
ponded to ascorbic acid and oranges. m  the other it was 
hypochromic. it did not at first respond to iron, but 
responded to iron after a considerable amount of vitamin 
o had been administered, m  this case, the anaemia, 
though in the main due to iron deficiency, is thought to 
be directly related to the vitamin deficiency (page 27). 
Rohmer and uinaschedler (1932) have reported on similar 
cases, which required b o t h  iron ana vitamin u for the 
cure of the anaemia.
wennings and olazebrooK (1938) described two cases of 
scurvy, in one of which there was severe megaloeytic an­
aemia associated with low aseoxbie acid values, while in 
the other there was moderate normocytic anaemia and the 
degree of vitamin deficiency was less severe. This led
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them to suggest that there might be some relationship 
between the degree of vitamin c deficiency and the point 
at which marrow cell maturation is chiefly affected* in 
the present series, red cell size was not measured; but 
no correlation could be made out between the colour in­
dex and ascorbic acid level, as the diagram (figure 13) 
indicates.
Reticulocytes;- It has been reported that the 
numbers of reticulocytes in untreated scurvy may be above 
normal (Mettier and Chew, 1932; Euler and Malmberg, 1937; 
Nisenson and Cohen, 1937; Jennings and Glazebrook, 1938; 
Dunlop and Scarborough, 1938). Armentano (1938) found 
that the number of reticulocytes increased as the anaemia 
became more severe in scorbutic guinea pigs. Respecting 
the effect of administration of vitamin C, Ungley (1938), 
who observed a wspontaneous retieulocytosis" in scurvy, 
was unable to demonstrate the specific effect of vitamin 
C in the anaemia of scurvy; but a reticulocyte response 
following the administration of vitamin c was observed 
by Dunlop and Scarborough (1938), Jennings and Glaze­
brook (1938) and Mettier and his co-workers (Mettier
TABLE 7
Relationship between red cell count and reticulocyte 
count before institution of treatment, and reticulocyte 
count at peak of crisis following institution of 
treatment, in anaemia of vitamin C deficiency.
Case Red Cell Count 
before treatment, 
(millions/cu.ram.)
Reticulocytes
Before treatment 
per cent.
At peak 
per cent
Day of
reaching
peak.
10 3.8 0.8 3.6 5
16 3.6 1.2 4.2 9
8. 3.5 0.8 3.8 5
11 3.21 0.9 3.4 6
17 2.78 2.4
12 2.7 2.6 6.5 4
15 2.48 2.4 8.2 7
9 2.26 3.0 15.2 6
17 2.0 3.9 25.2 5
7 1.95 1.9 14.6 5
15 1.9 1.6 2.5 5
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et al., 1930: Mettier and ohew, 1932). Ascorbic acid 
has no such effect on the reticulocyte count in normal 
individuals (Gingold, 1936, 1937).
In the present series also, it was observed that 
the reticulocyte count was raised in all the anaemic 
cases, and it varied roughly in inverse proportion to 
the red cell count, as the scatter diagram (figure 1% ) 
indicates, in the seven cases of scurvy in group II, 
a reticulocyte crisis followed the administration of 
ascorbic acid, and in three of the four cases in group 
III (the fourth, having an iron deficiency, being ex­
cluded at present) a reticulocyte crisis followed ad­
ministration of ascorbic acid with the addition of or­
anges or hesperidin. The height to which this crisis 
rose was inversely proportional to the red cell count, 
as the scatter diagram (figure 15 ) indicates, from 
this diagram it can be seen that the crisis which fol­
lows the initiation of successful treatment in the an­
aemia of vitamin C deficiency is comparable with the 
crisis under similar circumstances in other types of 
deficiency anaemia.
Mettier et al. (1930) reported that the reticulo­
cyte crisis in treated scurvy occurred sooner than
that in pernicious anaemia. They considered that this 
could be explained by the presumably longer process of 
maturation from megaloblast to erythrocyte in pernicious 
anaemia, whereas in scurvy, maturation would have to 
proceed through the shorter process from normoblast to 
erythrocyte. But there does not in fact seem to be any 
material difference between the times taken for matur­
ation from the megaloblast and from the normoblast;, be- >■ 
cause the length of time between initiation of treatment 
and reticulocyte crisis is about the same for pernicious 
anaemia and for iron deficiency anaemia. According to 
Wintrobe (1942b) the increase in reticulocytes in iron 
deficiency anaemia is maximal on the fifth to the tenth 
day after institution of iron therapy, and according to 
Whitby and Britton (1942 ) the reticulocyte response in
pernicious anaemia reaches a peak on the third to the 
tenth day; in a series of twelve cases of pernicious an­
aemia described by Davidson et al. (1942) the peak was 
reached on the fourth to the sixth (mean *fifth) day. 
in the present series (of cases of the anaemia of vita­
min c deficiency), the peak was found to occur on the 
fourth to the ninth (mean « sixth) day after institut­
ion of vitamin c therapy. Thus, maturation appears
Table 8>
Schilling Count: mean values and standard deviation (S.D.) 
before and after treatment
Before After
Treatment Treatment
Group Groups All
I II and III Groups
Mean S.D. Mean S.D. Mean S.D.
Basohpils 0.9 0.5 0.7 0.7 1.1
Eosinophils 1.5 1.4 0.2 0.3 0.6 0.7
Juveniles 0.7 0.4 0.5 0.4 1.0 0.5
Staffs 3.0 0.4 1.1 0.7 3.2 0.4
Segmented Neutrophils 51.0 6.7 46.4 10.9 51.9 7.1
lymphocytes 35.3 ' 6.5 43.7 7.1 35.7 6.9
Monocytes 8.6 1.4 7.6 2.4 6.9 2.5
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to take about the same length of time in the anaemias of 
iron and of vitamin c deficiency and in pernicious anaemia 
under appropriate treatment.
White uell uount: - Gulland and Goodall (1925) stated 
that in scurvy the number of white cells was diminished, 
in the absence of recent haemorrhage, while .einey (1932; 
stated that sometimes a leueocytosis occurred, but that 
oftener the number of white cells was normal. Mettier 
et al. (193u) gave the number of white cells in uncom­
plicated cases as from four to six thousand per cubic 
millimetre, parsons and Smallwood (1935; found no con­
stant change, m  guinea pigs with experimental scurvy, 
Uiblicek and hucera found a leucopenia, while Mouriquand 
et al. ^193b; found that there was first a leueocytosis, 
then a leucopenia as the scurvy advanced.
imo constant changes were found in the present series. 
The mean white cell count, of all the cases in which there 
was anaemia, was rather low, being 4,9u0 per cubic milli­
metre. The high standard deviation ( « l,25o ) indicates 
the variability of the individual counts.
schilling uount: - Schilling (1929; described right
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shift with neutropenia in scurvy. Comrie (1920) stated 
that there was a slight relative lymphocytosis, with no 
increase in monocytes, often a few myelocytes, and a 
scarcity of basophils. m  guinea pigs, Mouriquand*found 
that the numbers of monocytes increased as the scurvy 
became more severe; and Diblicek and i^ucera (1933) found 
an increase in basophils and eosinophils.
Table 8 shows the mean values in the present series. 
From this table it can be seen that the Schilling count in 
group i showed no abnormality despite the vitamin 
deficiency. Taking as standard the mean of all seventeen 
oases after treatment, it appears that the proportions of 
segmented neutrophils and monocytes were not significantly 
affected by the vitamin deficiency. jvjo statement can be 
made concerning alterations in the proportions of 
eosinophils and basophils, on account of their variability;
i
but the rarity of basophils in untreated scurvy, to which 
Mettier et al. (193u) referred, was not apparent. There 
was a diminution in the numbers of juveniles and staffs; 
the difference between the mean values before and after 
treatment/
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treatment being more than twice the standard error (S.E.} 
in the case of the juveniles (S.E. s 0.2 ) and more than 
four times in the case of the staffs (S.E. « 0*4 ;. There 
appeared to be a slight ljimphocytosis before treatment, 
the difference between the numbers before and after treat- 
jment being more than twice the standard error ( s 2.7; 
These figures suggest that there wqs a slight degree of 
"right shift- in those cases of vitamin c deficiency in 
which anaemia, presumably attributable to the deficiency, 
was found.
The formula used for the calculation of the standard
il and i n  ) being eleven, and tvz (the total number of 
cases treated; being seventeen.
Cooke Count: - A shift to the right in the Arneth 
count >01' which this is a modification^ is said to occur in 
scurvy (Schilling 1929} and was found in the cases in 
groups il andlll in this series, the mean "weighted mean" 
being 5.2 (S.D. • 0.2; before treatment, and 2.6 after 
treatment.
error was
The sample was small; t v * (the number of cases in groups
DONE/
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bOm MARROW: -
eellularity: - Rost-mortem studies of the bone
marrow have been reported by iMaegeli (1932), narris (1927),
Shipley (1933), nolt and mclntosh (1933) and MacCallum
(1938), who describe the disappearance oi the blood-forming
tissues and their replacement by fibrous tissue, Riney
(1932) stated that the marrow was hypoplastic, Dalldorf
(1938) stated that atrophy occurred, wolbach (1937)
described large areas of an amorphous material resembling
amyloid, m  biopsy material, hyperplasia has been
described, Mettier et al. (193o) and Jennings and 
(1938)
Glazebrook/ described hyperplasia in bone marrow removed 
by sternal puncture. markedly increased eellularity was 
noted, in the bone marrow of guinea pigs that had died 
of scurvy, by mettier and Chew (1932).
increased eellularity was a constant feature in the 
anaemic cases in the present series. The photo­
micrographs (figures 3  and 4 . ,  facing page 9 ) illustrate 
the difference between the eellularity of the films from 
-one case of scurvy before and after treatment.
Differential count: -/
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Differential Count:- Mettier et al. (1930) 
carried out sternal puncture on a case of scurvy 
before treatment,and on another at the height of 
the reticulocyte crisis following ascorbic acid 
administration. In the first they found scattered, 
small, varying-sized groups of nucleated red cells, 
many myelocytes among which were many of the eos­
inophilic variety, adult polymorphs and megakaro- 
cytes in moderate numbers, and no evidence of fib­
rosis. In the second there were quantitatively more 
nucleated red cells, and in each field there were 
mitotic figures in the red cell precursors, a feat­
ure that had not been apparent in the first case. 
Jennings and Glazebrook (1938), in two cases, found 
in both, a relative increase in the numbers of the 
earlier red cell precursors, and in the more severe 
case, "definite hyperplasia, the early red cells be* 
ing more affected than the white ce^-ls". Mettier 
and Chew (1932) found that the bone marrow of guinea 
pigs that had died of scurvy contained "large numb­
ers of erythrogenic cells, mainly normoblasts, which 
showed little evidence of active maturation", but 
when/
6*
when remission had been induced by giving orange juice, 
there were relatively more adult red cells than in the 
marrow of untreated cases.
To summarise, it has been stated that there is an 
increase in the numbers of nucleated red cells, some- 
:times affecting to a greater extent the earlier types, 
during untreated scurvy; during treatment there is an 
increase in mitotic activity in the red cell precursors. 
An increase in myelocytes has been observed in the 
untreated phase,
in the present series, increased numbers of the
pre
earlier types of red cell precursors and oy myelocytes 
were observed in the cases of scurvy, before treatment. 
These changes are made clearer by the calculation of the 
maturity dispersions, and are referred to below. m  
cases 11, 12 and 13 marrow was aspirated during the 
reticulocyte crisis that took place after treatment was 
begun. it could not be clearly shown that the numbers 
of mitotic forms of the normoblasts were higher than 
they had been before treatment, though the numbers were
definitely/
TABLE 9
Maturity Dispersal Ratios: Granuloblast and Erythroblast
before and after treatment. The standard error (S.E.) is 
that of the difference between groups II and III before 
treatment, and groups I, II and III after treatment.
Before treatment After
treatment
Group I Groups II 
and III
Groups I,II 
and III
Mean S.D. Mean S.D. Mean S.D. S.E.
Granuloblast.
Myeloblasts 5.5 1.6 6.1 6.4 4.6 2.0 2.0
Promyelocytes
Myelocytes
Juveniles
15.0
36.6
44.9
1.9
2.8
4.2
22.3
38.3
34.3
4.5
5.5 
6.9
14.5
35.6 
45.3
4.4
3.6
5.2
1.7
1.3
Erythroblast. 
Pronormoblast 
Basophilic 
normoblasts 
Polychromatic and 
Orthochromat ic 
normoblasts
2.0
15.1
82.9
1.1
5.2
4.9
3.4
44.3
52.3
1.8
9.1
7.2
2.3
16.1
81.6
1.2
6.0
5.9
0.6
3.1
2.6.
6S
definitely higher during the crisis than after treatment. 
Megakaryocytes were always found, though in some specimens 
they had to be sought in several films.
Maturity Dispersal Ratios: - Table 9 shows how the 
means compare, before and after treatment. From this 
table, it is seen that the maturity dispersions of both 
granuloblast and erythroblast in group I were within 
normal limits. in groups II and III, however, certain 
deviations from the normal were noted as follows: -
Granuloblast; - There was no demonstrable change in 
the percentages of myeloblasts or myelocytes, but there 
was a significant increase in the promyelocytes and a 
corresponding reduction in the juveniles,
Erythroblast: - There was no demonstrable- change in 
the pronormoblasts. There was a definite normoblastic 
reaction, in the form of a significant increase in the 
basophilic forms of the normoblast, with a corresponding 
decrease in the polychromatic and orthochromatic forms.
In six cases of iron deficiency anaemia with 
haemoglobin levels that gave a mean near that of the 
vitamin/
T A B L E  1 0
Comparison of maturity dispers Lon of erythroblast 
in vitamin C deficiency anaemia (cases 7 to 17) and 
iron deficiency anaemia (six cases).
Vitamin C 
deficiency. Iron deficiency.
Haemoglobin, per cent. 59 52
Red cell count (ntiOions/
cu. mm.) 2.9 3.7
Pronormoblasts 3.4 4.4
Normoblasts
n Basophilic 44.3 17.2
i i Polychromatic and)
al Orthochromatic ) 52.3 78.3
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Vitamin C deficient cases of groups II and III, this 
increase in basophilic normoblasts was not a feature, 
as can be seen from table ItD0 , However, increased 
numbers of basophilic normoblasts are known to be a 
feature of iron deficiency anaemia (Piney 1941) so that 
the probability is that the means of the iron deficient 
and vitamin C deficient anaemias in table iO are not 
comparable, since the cell count in the iron deficient 
cases is higher than in the vitamin C deficient. This 
is partly supported by the finding that in vitamin C 
deficiency anaemia, there is an inverse relationship 
between the red cell count and the percentage of baso- 
ijihilic normoblasts (figure 16 )/
While there was an increase in the percentage of 
basophilic normoblasts before treatment, no further 
increase with the institution of treatment was observed; 
there was rather a gradual return to normal. Similar 
findings have been reported of post-haemorrhagic anaemia 
during treatment (Piney, 1941)•
GASTRIC ANALYSIS: - Achlorhydria was a feature in
the/
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the four cases that failed to respond to ascorbic acid, 
whereas there were normal amounts of free hydrochloric
acid in the cases that did respond.
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DISCUSSION.
It is commonly accepted that vitamin C plays some 
part in erythropoiesis. Difference of opinion exists 
as to the actual part itplays. Thus it has been 
thought to be a stimulant to red cell formation (Lichwitz, 
1942)• others nave thought it to be a specific 
erythropoietic factor, in the absence of which maturation 
cannot proceed; while others again have thought it to 
be no more than an adjuvant, which may be taken as meaning 
that it facilitates the utilisation of erythropoietic 
substances, but is not itself indispensable as an 
erythropoietic factor.
it is unlikely that vitamin c merely stimulates 
maturation since it has no demonstrable effect on the 
normal subject (Gingold, 1936, 1937). But there is a 
certain amount of evidence for both the view that it is a 
specific erythropoietic factor, and for that that it is 
an adjuvant,, and this evidence must be considered. •
The characteristic response to the administration of
«/
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fspecific erythropoietic substance which has been 
lacking, is a reticulocyte response followed by a rise in 
red cells and haemoglobin (Israels and Wilkinson, 1936), 
Such a response to the administration of vitamin c in the 
anaemia of scurvy has been observed (Jennings and 
Glazebrook, 1938; iviettier and chew, 1932; rarsons and 
Smallwood, 1935;, it whs observed in the present 
series also, and the charts (pagesIv to Lev , appendix; 
illustrate the type of response, while figure 14 (facing 
page 57 ; shows that the reticulocyte response was 
comparable with that of other types of anaemia under 
adequate treatment,
it may be accepted, then, that the vitamin plays a 
part in erythropoiesis. But there are objections to 
regarding it as a specific erythropoietic factor. Thus, 
the presence or absence of anaemia is not related to 
the degree of vitamin c deficiency, as scurvy may occur 
without anaemia (Rohmer and Bindschealer, 1932; crandon 
©t al, 1941;, and ascorbic acid values as low as those 
of scurvy may occur in the absence of either scurvy or 
anaemia/
anaemia (Croft and bnorf, 1939;, i*he latter observation 
has been made in this series (page 40 j. Again,' the 
response of the anaemia of scurvy to vitamin o is not 
always or the specific type; thus, Ungley (1938) 
observed a "spontaneous reticulocytosifif* in scurvy and was 
unable to demonstrate the specific efiect or vitamin c, 
while McMillan and mglis (1944; failed to observe a 
reticulocyte response although* the red cells and 
haemoglobin rose on tne administration of the vitamin. 
1‘inally, vitamin c, in the form of pure ascorbic acid, has 
sometimes failed to effect any change in the anaemia of 
scurvy until some other factor was added ( page 45) , and 
Bohmer and Binaschedler (1932) round that in some cases 
both iron and vitamin c were necessary. m  the present 
series, there were four cases of severe vitamin c 
deficiency with anaemia which failed to respond to 
ascorbic acid; in two casesj response was obtained on 
the addition of oranges; in the other two, it appeared 
that iron in the one, and vitamin j? in the other, were 
required as well as ascorbic acid ( page$ 31) p
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it is therefore probable that vitamin c is a factor 
of some importance in erythropoiesis, but that it is of 
secondary importance, in that it facilitates the 
utilisation of other, erythropoietic substances; while 
erythropoiesis can proceed, in spite ox gross ascorbic 
acid deficiency, if tnere is an adequate supply of these 
other substances*
The blood and bone marrow in the anaemia of vitamin 
C deficiency, and changes in these as *a result of 
treatment, will now be considered for the purpose of 
reaching a conclusion as to the level or levels at which 
erythropoiesis is held up in the anaemia of vitamin c 
deficiency* This might be expected to give information 
supporting one or other of the theories discussed above. 
Thus, if there was a specific anaemia of vitamin 0 
deficiency, one might expect to iind some constant and 
possibly also characteristic type of response to both the 
deficiency itself and the treatment of it* if vitamin C
acts as an adjuvant only, one would expect to> fiitd a 
variable/
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variable picture in the deficiency, and a variable response 
to treatment; or if a constant picture was found, that 
it would be such as could be round in other types of 
anaemia.
The anaemia of vitamin c deficiency will be compared 
with other types of anaemia, in which the ©rythropoietio 
factors act at different levels; for example with 
pernicious anaemia ana with iron deficiency anaemia. 
Comparisons will be made in respect of the following 
\a> colour index and cell size; (b) response to treatment; 
(cj bone marrow picture; and (dj response or bone marrow 
to treatment,
colour index and cell size: - it is commonly 
accepted that the anaemia is usually orthochromic, 
through hypercnroraic ana hypochromic types also occur 
I page 53 j . This was found to be the case in the present 
series, it is stated also that the anaemia is usually 
normocytic though it may occasionally be macrocytic 
iWhitby and Britton, 1942^. jefcnings and Glazebrook 
-(1938^ considered that this variation indicated that the 
vitamin/
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Vitamin acts through a wide range of maturation, but 
that a severe deficiency might lead to maturation being 
held up at an earlier phase and so giving rise to 
macrocytosis• wintrobe (1942; stated that macrocytosis 
may occur, in anaemias usually normocytic, ii blood 
formation is stimulated, since young red cells are 
larger tnan the older cells# fhis may partly account 
for the occasional r inaing or macrocytosis in tne 
anaemia or vitamin c deficiency, as there is oiten an 
increased reticulocyte count in the more severe anaemias 
(page^S;. it rails to account for the occurrence of 
macrocytosis with hyperchromia# since the hold up in 
maturation or the megaloblast in pernicious anaemia gives 
rise to a large-celled anaemia, while in iron deficiency 
the hold up in maturation of the normoblast gives rise 
to a small-celled anaemia, one assumes that in 
dyshaemopoietic anaemias, the larger-celled anaemias are 
due to a hold up in maturation at an earlier phase than 
in the case of the smaller-celled anaemias# if this is 
true, it would imply that in the anaemia of vitamin c 
deficiency/ <
I74-
deficiency in some cases the hold up is at an earlier 
phase than in others.
lb) Response to treatment; - The curve correlating 
the red cell count before treatment with the percentage 
of reticulocytes at the peak of the crisis in pernicious 
anaemia is different from that in iron deficiency 
anaemia. The difference, however, is small. m  the 
present series the relationship did not give a 
sufficiently clear curve or a sufficiently close 
approximation to either the pernicious anaemia or the 
iron deficiency anaemia curve to allow of any conclusion 
being drawn from this comparison ifigure IS , facing 
page 57 ).
mettier et al. (1930) have stated that the interval 
between initiation of treatment and the reticulocyte 
crisis is Shorter in scurvy than in pernicious anaemia. 
They have offered as an explanation that in scurvy the 
erythrocyte has only to undergo the relatively short 
process of maturation from the normoblast, whereas in 
pernicious anaemia it has to undergo the longer process 
of/
Of maturation from the megaloblast* it appears, however,
!
that there is no material difference between the 
interval in pernicious anaemia and that in iron 
deficiency anaemia, and in scurvy the interval was 
found to be of the same order (page S& ), Thus no 
conclusion can be based on observations of the interval 
between the initiation of treatment and the reticulocyte 
response*
(c) Bone marrow: - in all the anaemic cases described 
in this paper - fifteen in number - the erythroblast 
showed a very constant change: namely, an increase in
basophilic normoblasts with a corresponding decrease in the 
ortho chroma tic and polychromatic forms* There was no 
material change in the pronormoblasts* This picture 
appears to resemble that of iron deficiency in which Biney 
(1942) described an increase in the basophilic normoblasts* 
it bears no resemblance to the megaloblastic marrow of 
untreated pernicious anaemia, although it resembles the 
picture early in the course of treatment of pernicious 
anaemia, just after the megaloblastic has given place to
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a—normoblastic picture.
(d) Response of bone marrow to treatment: - as 
in the ease of iron deficiency under treatment (Jpiney, 
1933) no increase in the number of basophilic normoblasts 
took place with the institution of treatment, but there 
was rather a gradual return to normal. in this respect 
again there was no resemblance to pernicious anaemia in , 
which there is a rapid change from a megaloblastic to 
a normoblastic picture, followed by a steady return to 
normal (Davidson et al., 1932).
From the foregoing it appears, from the general 
similarities with iron deficiency anaemia, that a 
parallel may be drawn between that and vitamin C 
deficiency. The point of action of iron must therefore 
be considered.
Finey (1942) deduced that iron was needed for 
complete maturation of the erythroblast and not as a 
stimulant to erythropoiesis, because the great excess of 
immature normoblasts in the bone marrow of the untreated 
case did not further increase after iron therapy had been 
instituted./
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instituted. presumably, the administration of iron 
allows erythropolesis to proceed beyond the point at 
which it had been held up when iron was deficient.
"Iron is essential for the proper production of fully 
haemoglobinised red corpuscles and a deficiency 
affects that stage of erythropoiesis at which haemo- 
:globin is being rapidly assimilated by the ripening 
corpuscles" (Whitby and Britton, 1942), in the 
nomenclature used in this paper, the point of action 
would be at.the phase of maturation from the basophilic 
normob&ast to the orthochromatic normoblast. A hold 
up at this point would yifeld an increase in basophilic 
normoblasts, either relatively, or absolutely, in an 
attempt to compensate for decreased production of later 
forms.
Similarly, in the case of vitamin c deficiency 
anaemia,the observed increase in basophilic normoblasts 
could be taken to indicate that the vitamin acts 
chiefly at the point of maturation from the basophilic 
to the polychromatic form. The progressive decrease in 
the percentage of basophilic forms after the institution 
of/
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of treatment would indicate that the vitamin did not 
act as a stimulant to erythropoiesis, but by allowing 
some deficiency to be filled, allowed maturation to 
proceed. The occasional variation in the colour 
index could be taken to indicate that the point of 
action could vary to a certain extent within the 
normoblastic range.
It has been thought that vitamin c would act 
throughout the whole range of maturation, because 
vitamin C is essential for cell metabolism (parsons 
and Smallwood, 1935) • But iron also can be regarded 
as acting through the whole range of erythropoiesis; 
because haemoglobin can be detected in the ortho- 
iplastic pronormoblast (Wintrobe, 1942). Despite 
this, it is apparently at the early normoblastic level 
that both iron and vitamin u have their chief effect. 
This is probably related to the fact that it is at 
this level that the most active cell division takes 
place, as is stated by Doan, Cunningham and sabin (1925); 
as the cells are proliferating more actively at this 
level/
7S
level, they would require larger ©mounts of vitamin c and 
iron, as well as other factors.
Thus there is nothing characteristic about the 
anaemia of vitamin u deficiency. The constant finding 
of increased numbers of basophilic normoblasts appears 
to be such a finding as might be expected in an anaemia 
in which the blood-forming tissues were reacting and 
giving a raised reticulocyte count; just as acute 
haernolytic anaemia may give a high reticulocyte count 
and a marrow showing extreme normoblastic "hyperplasia", 
and acholuric jaundice give a marrow showing "erythro- 
:poietic nyperplasia of the normoblastic type" (Wintrobe 
1942).
The findings as to the blood and bone marrow and 
their reponse to treatment therefore favour the view 
that vitamin c is an adjuvant to erythropoiesis, 
since the variable type of anaemia suggests that the 
hold up in maturation may be at different levels in 
different cases. The reticulocyte response, the bone 
marrow picture and its response to treatment, are in no 
way/
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way characteristic of vitamin c deficiency, but are 
such as may be found in several other conditions.
The polymorphonuclear neutrophils show a similarly 
uncharacteristic picture. i,eucopenia is frequent but 
inconstant (page59) and there is generally a right 
shift, because of the large proportion of multilobed 
(and so presumably senile) polymorphs (page 59). The 
bone marrow snows a correspondingly increased proportion 
of promyelocytes in many cases (page OS) . It seems 
likely that the deficiency of vitamin c leads to delayed 
formation of polymorphonuclear neutrophils; this would 
account for the common neutropenia and the decreased 
numbers of young forms in the peripheral blood.
it is likely that vitamin C is a substance of 
importance in cell metabolism, by regulating tissue 
respiration (Euler and klussman, 1933) so that there is 
nothing inherently improbable about the vitamin’s having 
an action on both red cell and while cell formation; 
dtamay be rhat the diminished respiration and metabolism 
during the vitamin deficiency are the cause of the 
imperfect utilisation of erythropoietic substances and of 
the delayed formation of polymorphonuclear neutrophils.
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UONCLUSIOHB
V-
Vitamin C has an effect on red cell and on white 
cell formation.
It is probable that it acts as an adjuvant to red 
cell formation, by facilitating the utilisation of other 
haemopoietic factors,
on both red cell and white cell (neutrophil 
granulocyte; formation the action of the vitamin is 
non-specific and may be related to the postulated role 
of the vitamin in cell metabolism.
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SUMMARY.
Twenty one cases of severe vitamin c deficiency, 
including thirteen cases of scurvy, are studied.
The blood and bone marrow pictures and the effects 
of treatment are considered.
Theories as to whether or not vitamin C is an 
erythropoietic factor are discussed.
Reasons are given for concluding that the vitamin 
does not play a specific part in erythropoiesis.
as
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- A P P E N D I X  :
Protocols of all cases of vitamin C deficiency 
in the series; tables I - X2X;pp i to liv.
Blood charts, cases 7 to 17-pp lv to lxv.
Table J
Case 1. Male aged 43 years. No sign of scurvy or other 
physical disease.
Treatment:- One thousand milligrammes ascorbic acid intra­
venously on 26.ix; and three hundred milligrammes ascorbic 
acid daily by mouth, from 26. ix
----  ■ ■ '1
Date 28. vii 26. ix 5.i
ASCORBIC ACID DETERMINATIONS
Rotter*s Test (time, minutes) 12 12 5
Plasma ascorbic acid (mgms.
per cent) 0.51 0.49 1.5
CAPILLARY FRAGILITY 3 4 2
BLOOD EXAMINATIONS.
Haemoglobin ( % ) 102 101 102
Colour Index 1.06 1.06 1.03
White dell count (/cu.mm.) 8,600 5,400 5,800
Schilling Count
Basophils 0,5 0.5 1.0
Eosinophils - 0.25 0.2
Myelocytes - - -
Juveniles 1.0 1.0 1.0
Staffs 3.5 3.75 2.25
Segmented Neutrophils 60.0 58.0 56.0
Lymphocytes 24.0 27.5 31.0
Monocytes 11.0 9.0 8.5
Cooke Count - weighted mean 
Platelet Count (/cu.mm.)
2.7
275,000
2.7 2.6
Table X (contd.)
Date 28.vii 26. ix 5.i
BONE MARROW
Cellularity
Differential Count 
Myeloblasts 1.6 1.2 1.2
Promyelofeytes 3.6 3.2 2.4
Neutrophil myelocytes 9.6 7.2 8.0
k " juveniles 12.0 10.8 13.6
w staffs 11.2 11.6 12.4
" segmented 13.6 14.0 13.2
Eosinophil myelocytes - 0.4
M segmented 0.4 - 0.4
Basophil myelocytes 0.4 0.4 -
M segmented 0.4 1.2 0.4
lymphocytes 8.0 8.8 6.4
Monocytes 2.0 2.0 1.6
Plasma cells 1.6 2.0 1.2
Pronormoblasts 0.8 0.4 0.8
Normoblasts
Basophilic 2.8 2.8 1.6
Polyc hromat ic 30.0 34.4 33.2
Orthochromatic 2.0 — 3.2
Mitotic forms 0.4 0.4 -
Maturity Dispersal Ratios 
Granuloblast 
Myeloblasts 5.9 5.4 4.7
Promyelocytes 13.1 14.2 9.4
Myelocytes 36.8 32.4 32.7
Juveniles 44.2 48.0 53.2
Erythroblast
Pronormoblast 2.2 1.2 2.0
Normoblast - basophilic 7.8 7.4 4.0
" polychromat­
ic and ortho- 
chromatic 90.0 91.4 94.0
Table H
Case 2. Male aged 43 years. No sign of scurvy or other 
physical disease.
Treatment:- One thousand milligrammes ascorbic acid intraven­
ously on 7«xii; and three hundred milligrammes ascorbic acid 
daily by mouth from 7*xii.
Date 7.viii 7.xii 8.i
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 14 11 5
Plasma ascorbic acid (mgms.
per cent) 0.46 0.48 1.4
CAPILLAR! FRAGILITY 
BLOOD EXAMINATIONS
Haemoglobin ( % ) 92 93 92
Colour Index 1.03 0.99 1.0
White cell count ( /cu.mm.) 5,600 5,800 5,000
Schilling^ Count
Basophils - - -
Eosinophils 2.5 2.0 1.25
Myelocytes - - -
Juveniles 1.0 1.25 -
Staffs 2.5 2.0 2.5
Segmented Neutrophils 55.25 50.0 48.0
lymphocytes 31.75 38.0 41.25
Monocytes 7.0 6.75 8.0
Cooke Count - weighted mean 
Platelet Count ( /cu.mm.)
2.5
350,000
2.6 2.6
T v T
Table 3X (contd.)
Date 7.viii 7.xii 8.i
BONE MARROW 
Cellular ity 
Differential Count
Myeloblasts 2.0 2.0 1.2
Promyelocytes 2.4 5.2 4.0
Neutrophil myelocytes 8.4 8.0 9.2
M juveniles 12.0 9.6 10.0
M staffs 17.2 15.6 17.6
" segmented 18.0 17.2 20.4
Eosinophil myelocytes - 0.8 0.4
” segmented 0.8 - -
Basophil myelocytes - - -
" segmented - - 0.4
lymphocytes 4.0 2.0 2.0
Monocytes 1.2 1.6 0.4
Plasma cells 0.8 0.8 0.8
Pronormoblasts - 0.4 0.8
Normoblasts
Basophilic 3.2 5.6 5.2
Polychromatic 26.0 30.0 25.6
Orthochromatic 4.0 1.2 2.0
Mitotic forms - - 0.4
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 8.0 7.7 4.8
Pronyelocytes 9.7 20.3 16.4
Myelocytes 33.9 34.4 38.4
Juveniles 48.4 37.6 40.4
Erythroblast
Pronormoblast - 1.1 2.4
Normoblast - basophilic 9.5 15.1 15.3
polychrom­
atic and or­
thochromatic 90.5 83.8 82.3
Table. HI
Case 3. Male aged 49 years. N o  sign of scurvy or other 
physical disease.
Treatment:- One thousand milligranmes ascorbic acid on 
15.iij and three hundred milligrammes ascorbic acid daily 
by mouth from 15.ii
Date 9.viii 15. ii 21.iii
ASCORBIC ACID DETERMINATIONS
Rotter*s Test (time, minutes) 14 9 3
Plasma ascorbic acid.(mgms.
per cent.] 0.5 0.51 1.8
CAPILLARY FRAGILITY 2 4 -
BLOOD EXAMINATIONS
Haemoglobin (%) 91 89 94
Colour Index 1.04 1.05 0.9
White cell count ( /cu.mm.) 4,000 3,600 9,500
Schilling Count
Basophils - - -
Eosinophils 0.25 0.5 0.5
Myelocytes - - -
Juveniles 1.0 - 1.5
Staffs 3.0 5.75 3.0
Segmented Neutrophils 51.0 60.0 57.25
lymphocytes 36.0 27.75 31.0
Monocytes 8.75 9.0 7.0
Cooke Count - weighted mean 
Platelet Count ( / cu.mm.)
2.6
250,000
2.7 2.6
Table 'IK (contd.)
Date 9.viii 15. ii 21.iii
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 1.6 1.2 1.6
Promyelocytes 4.0 3.6 3.2
Neutrophil myelocytes 9.6 8.4 9.2
rt juveniles 10.0 11.6 10.8
M staffs 12.0 13.2 11.6
M segmented 15.6 16.4 15.2
Eosinophil nyelocytes 0.8 - -
” segmented 0.4 - -
Basophil myelocytes - - 0.4
M segmented - - 0.4
lymphocytes 4.4 4.0 3.6
Monocytes 1.6 0.8 1.6
Plasma cells 0.8 1.6 1.2
Er onormob1ast s 1.2 0.8 0.8
Normoblasts
Basophilic 7.2 8.0 8.0
Polychroraat ic 27.2 28.4 31.2
Orthochrcanatic 3.6 2.0 1.2
Mitotic forms 0.8 - -
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 6.1 4.8 6.4
promyelocytes 15.4 24.6 12.9
Myelocytes 40.0 33.8 37.1
Juveniles 38.5 46.8 43.6
Erythroblast
Pronormoblast 3.0 2.0 1.9
Normoblast - basophilic 18.0 20.4 19.3
polychromat­
ic and orthow
chromatic 79.0 77.6 78.8
Table W
Case 4. , Male aged 41 years. No sign of scurvy or other 
physical disease.
Treatment:- One thousand milligrammes ascorbic acid intra­
venously on 23.ii; and three hundred milligrammes ascorbic 
acid daily by mouth from 23.ii
Date 14. i 23. ii 2.iv
ASCORBIC ACID DETERMINATIONS
Rotter*s Test (time, minutes) 10 10 4
Plasma ascorbic acid, (ragms
per cent.) 0.58 0.56 1.6
CAPILLARY FRAGILITY 3 2 2
BLOOD EXAMINATIONS
Haemoglobin (/o) 110 107 107
Colour Index 1.18 1.13 1.21
White cell count ( /cu.mm.) 9,800 11,000 8,600
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
Lymphocytes
Monocytes
3.73
2.75 
43.0 
41.75
8.75
6.25
1.0
2.0 
40.0 
36.5 
14.25
3.0
0.2 5 
2.75 
43.75 
38.0 
12.25
Cooke Count - weighted mean 3.0 2.9 2.8
Platelet Count (/cu.ram.) 400,000
Table K  (contd.)
Date 14. i 23. ii 2. iv
BONE MARROW
Cellularity
Differential Count 
Myeloblasts 1.2 2 .0 2.0
Promyelocytes 4.0 3.2 4.4
Neutrophil myelocytes 9.6 8 .0 9.2
" juveniles 13.2 13.6 15.6
" staffs 10.4 14.8 9.6
rt segmented 14.4 17.2 12.4
Eosinophil myelocytes 0.8 - -
" segmented 0.4 0.4 -
Basophil myelocytes - 0.4 -
” segmented - - -
lymphocytes 2.4 5.6 3.6
Monocytes 1.6 2 .0 1.2
Plasma cells 0 .8 2 .0 1.2
Pronormoblasts 
Normoblasts 7.2 7.2 6.8
Basophilic 31.2 31.2 31.6
Polychromat ic 1.2 2 .0 1.6
Orthochroraatic 
Mitotic forms 0.4 - -
Maturity Dispersal Ratios 
Granuloblast 
Myeloblasts 4.1 5.9 5.4
PTonyelocytes 13.8 11.9 14.3
Myelocytes 36.1 31.3 29.8
Juveniles ,45.8 50.9 50.5 .
Erythroblast 
Tronormoblast 2 .0 1.9 2.9
Normoblast - basophilic 17.6 17.6 16.6
Polychromat­
ic and ortho- 
chromatic 80.4 80.5 80.5
Table ^
Case 5. Male aged 49 years. No sign of scurvy or other 
physical disease.
Treatment:- One thousand milligrammes ascorbic acid intra­
venously on 2.xi; and three hundred milligrammes ascorbic 
acid daily by mouth from 2.xi
Date 24.vii 2.xi 2.xii
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 14. 15 5
Plasma ascorbic acid. (mgms.
per cent.) 0.47 0.5 2 .0
CAPILLARY FRAGILITY 7 9 8
BLOOD EXAMINATIONS '
Haemoglobin: ($) 99 97 100
Colour Index 0.99 1.03 0.99
White cell count ( /cu.nm.) 4,800 5,800 6,200
Schilling Count
Basophils 5.2 7-0 3.5
Eosinophils 1.4 - 1 .0
Myelocytes - - -
Juveniles 0.4 0.25 0.5
Staffs 5.4 2.25 3.75
Segmented Neutrophils 45.6 59.5 42.0
Lymphocytes 58.2 25.5 38.5
Monocytes 7.8 5.5 5.75
Cooke Count - weighted mean 
Platelet Count ( /cu.ram.)
2.7
220,000
2 .8 2 .6
XTable "V (contd.)
Date 24.vii 2.xi 2.xii
BONE MARROW
Cellularity
Differential Count
Myeloblasts 1.2 2.0 2 .0
Promyelocytes 4.0 4.8 4.8
Neutrophil myelocytes 11.6 8 .0 9.2
w juveniles 13.2 12.4 12.0
n staffs 9.6 9.2 11.2
" segmented 12.0 12.0 14.0
Eosinophil myelocytes 0.4 0 .8 -
11 segmented - - -
Basophil myelocytes - 0.4 -
1 segmented - - -
Lymphocytes 4.0 4.4 3.2
Monocytes 1 .6 2 .0 1 .2
Plasma cells 1 .2 1.6 1 .2
Pronormobla sts 0.3 1 .2 1 .2
Normoblasts
Basohpilic 7.2 8 .0 7.6
Polychromatic 30.0 31.6 30.0
Orthochromatic 3.2 1 .6 2 .0
Mitotic forms - 0 .8 0.4
Maturity Dispersal Ratios
Granuloblast
Myeloblasts 3.9 7.1 7.1
Promyelocyt es 13.1 17.1 17.1
Myelocytes 39.5 31.5 32.8
Juveniles 43.5 44.3 43.0
Erythroblast
Pronormoblast 1.9 2 .6 2.9
Normoblast - basophilic 17.7 18.6 18.2
polychromat­
ic and ortho-
chromatic 30.4 73.3 73.9 I
Table U
Case 6. Hale aged 45 years. Jfo sign of scurvy or other 
physical disease.
Treatment:- One thousand milligrammes ascorbic acid intra­
venously on 23. ix; and three hundred rill igranrr.es ascorbic 
acid daily by mouth from 23* ix
Bate
i - -  . ............
27.vii 23. ix 23.x
T
ASCOBBIC ACID DJ^TMilllATXQie
Hotter*s Test (time, minutes) 30 35 5
Plasma ascorbic acid. (lagms.
per cent) 0.42 0.44 1.9
CAPTLL4HI PEbGILITT 10 7 10 -
BLOOD iSM.flHATIOHS
Haemoglobin (;i) 97 95 98
Colour Index 1.04- 0.91 0.98
White cell count { /cu,m.) 5,200 4,600 7,600
Schilling Count 
Basophils
Bosiaophils 1 
Hyelocytes
Juveniles ! 
Staffs
Segmented jfeutrophils.
Lymphocytes
Monocytes
H
O 
© 
O 
© 
© 
© 2.0
0.5
4.0
47,25
37.5
8,75
0.5
1.0
0.5
2.5
38.25
47.0
10.75
Cooke "Count - weighted mean 2.5 2.7 2.6
Platelet Count ( /cu. m. ) 195,000 *
Table Z^L (contd.)
Date 27.viii 23. ix 23.x
BONE MARROW
Cellular it y
Differential Count 
Myeloblasts 1.2 0.8 1.2
Promyelocyt es 3.2 2.8 3.6
Neutrophil myelocytes 8.4 8.8 8.0
,f juveniles 12.4 12.0 13.2
” staffs 11.2 9.2 13.2 i
w segmented 12.8 10.8 13.6
Eosinophil myelocytes - 0.4 -
" segmented 0.4 - -
Basophil myelocytes - - 0*4
” segmented • - 0 .4 -
Lymphocytes 3.2 6.0 4.8
Monocytes 1.6 2.4 2.0
Plasma cells 2.0 2.0 —
Pronormoblasts 1.2 1.2 1.6
Normoblasts
Basophilic 8.4 9.2 8.0
Polychromatic 28.8 31.2 27.6
Orthochromatic 3.2 2.0 2.8
Mitotic forms - 0.8 -
Maturity Dispersal Ratios
Granuloblast
Myeloblasts 4.8 3.2 4.6
Promyelocytes 12.7 11.2 13.6
Myelocytes 33.3 37.1 31.9
Juveniles 49.2 48.5 50.9
Erythroblast
Pronormoblast 2.8 2.6 4.0
Normoblast - basophilic 20.2 19.6 20.0
polychrom­
atic and or­
tho chromatic 77.0 77.8 76.0
Table "^ 31
Case 7. Female, aged 68 years; moderately arteriosclerotic, 
with signs of scurvy - follicular haemorrhages and ecchtmoses 
on legs and red cells in urine.
Treatment:-, One thousand milligrammes ascorbic acid intra­
venously on 20.vii; and three hundred milligrammes ascorbic 
acid daily by mouth from 20,vii
Date 20,vii 28.vii lO.viii 10. ix 20. xi
ASC O R B IC  A C ID  
DETSRMIMATIONS
Rotter’s Test 40 5 4 5
(time, minutes)
Plasma ascorbic acid 
(mgms. per cent.)
CAPILLARY FRAGILITY
0.31
65 54 8
1.3
3
BLOOD EXAMINATIONS
Haemoglobin (/) 42 45 54 80 98
Colour Index 1.08 1.07 0.90 0.98 0.94
White cell count 4,600 4,400 5,200 4,600 5,000
( /cu.mm.) 
Schilling Count
Basophils - - 0.25 - -
Eosinophils 0.5 - - 0.5 -
Myelocytes - - - -
Juveniles 1.0 0.25 1.5 2.25 2.0
Staffs 1.0 2.0 5.5 5.5 3.25
Segmented Neutrophils 40.5 42.0 45.5 45.5 55.75
Lymphocytes 48.5 48.0 41.25 38.5 31.75
Monocytes 8.5 7.75 6.0 7.75 9.25
Cooke Count - weighted
mean
, 'Platelet Count ( /cu.mm,)
3.1
650,000
2.8 2.7 2.4 2.7
xiv
Table \Ztt (contd.)
Date 20.vii 20. xi
BONE MARROW
Cellularity
Differential Count
Myeloblasts G.8 1.2
Promyelocytes 6.4 4.0
Neutrophil myelocytes 10.4 9.6
,! juveniles 12.0 15.6
” staffs 12.8 10.4
” segmented 12.4 11.6
Eosinophil myelocytes 0.4 0.4
” segmented - -
Basophil nyelocytes -  . -
M segmented - —
Lymphocytes 1.0 3.2
Monocytes 0.8 2.8
Plasma cells _ 1.6
Pronormoblasts 2.8 0.4
Normoblasts
Basophilic 21.6 6.4
Polyc hromat ic 16.4 28.0
Orthoc hr omat ic 2.0 2.0
Mitotic forms 2.4 0.4
Maturity Dispersal Ratios
Granuloblast
Myeloblasts 2.7 3.9
Promyelocytes 21.3 13.0
Myelocytes 36.0 32.4
Juveniles 40.0 50.7
Erythroblast
Pronormoblast 6.4 0.9
Normoblast - basophilic 49.8 13.6
polychromatic and )
orthochromatic ) 43.8 85.5
b
Table Yifl.
Case 8. Male, aged 52 years, with signs of scurvy - follicular 
haemorrhages on legs and thighs, ecchymoses on legs, red cells in 
urine, sponginess of gums.
T r e a t m e n t O n e  thousand milligrammes ascorbic acid intravenously 
on 13* viii and three hundred milligrammes ascorbic acid daily by 
mouth from 13.viii.
t)ate 12.viii 17.viii
ASCORBIC ACID DETERMINATIONS
Rotter1s Test (time, minutes) 50 23
Plasma ascorbic acid.(mgms.
per cent) 0.35
CAPILLARY FRAGILITY 85 70
BLOOD EXAMINATIONS
Haemoglobin (%) 65 72
Colour Index 0.93 0.97
V/hite dell count ( /cu.ram.) 5,600 5,000
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented.Neutrophils
Lymphocytes
Monocytes
0.75 
0.25 
4 2.5 
47.5 
9.0
0.25
1.5
3.5 
45.25 
40.75
8.75
Cooke Count - weighted mean. 3.3 3.0
Platelet Count ( /cu.mm.) 450,000
Table VlBL (contd.)
Date 30.viii 18. ix
ASCORBIC ACID DETERMINATIONS
Rotter*s TAst (time, minutes) 5 5
Plasma ascorbic acid.(mgms.
per cent) 1.9
CAPILLARY FRAGILITY 4 5
BLOOD EXAMINATIONS
Haemoglobin (/) 75 95
Colour Index 0.89 1.03
White cell count ( /cu.mm.) 6,200 6,800
Schilling Count
Basophils - -
Eosinophils 0.25 0.5
Myelocytes - -
Juveniles 3.0 1.5
Staffs 3.0 4.75
Segmented Neutrophils 52.0 48.75
Lymphocytes 35.25 37.5
Monocytes 6.5 7.0
Cooke Count - weighted mean 3.8 2.7
Platelet Count ( /cu.mm.) 450,000
Table VUT (contd.)
Date 12.viii 18. ix
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 0.8 1.2
Promyelocytes 6.4 2.4
Neutrophil myelocytes 10.4 9.2
M Juveniles 9.6 11.2
" staffs 8.0 12.0
” segmented 9.6 34.0
Eosinophil myelocytes - 0.4
t! segmented - -
Basophil myelocytes - -
n segmented - -
Lymphocytes 6.4 6.4
Monocytes 1.6 0.8
Plasma cells 2.8 2.0
Pronormoblasts 1.2 0.8
Normoblasts
Basophilic 20.0 7.2
Polychromat ic 22.4 32.0
Ort hochr omat ic 0.8 0.4
Mitotic forms 0.8 -
Maturity Dispersal Ratios
Granuloblast
Myeloblasts 2.8 4.9
Promyelocytes 23.6 9.7
Myelocytes 38.3 39.4
Juveniles 35.3 46.0
Erythroblast
Pronormoblast 2.7 2.0
Normoblast - basophilic 45.3 17.8
polychormatic and 
ort hoc hr omat ic i 52.0 80.2
Table IX
Case 9. Male aged 65 years. Moderately arteriosclerotic with 
signs of scurvy - follicular haemorrhages and ecchymoses on legs 
and thighs.and red cells in urine; complaint of unusual dyspnoea 
on slight exertion for a week before admission.
Treatment:- One thousand milligrammes ascorbic acid intraven­
ously on 30.xi and three hundred milligrammes ascorbic acid daily 
by mouth from 30. xi
Date 29. xi 5.xii 28.xii
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 30 3
Plasma ascorbic acid (mgms.
per cent.) 0.34 1.7
CAPILLARY FRAGILITY 55 5
BLOOD EXAMINATIONS
Haemoglobin (%) 42 44 56
Colour Index 0.92 0.95 0.84
White cell count ( /cu.nnn.) 5,200 5,800 4,200
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
lymphocytes
Monocytes
1.0
1.5
42 .5
48.75
6.25
0.25
2.25
4.5 
43.0 
41.5
8.5
1.75
3.0
53.75
35.25
6.25
Cooke Count - weighted mean 2.9 2.7 2.7
Platelet Count ( /cu.mm.) 520,000
Table E  (contd.)
Date 29. xi 8.xii
BONE MARROW
Cellular it y
Differential Count 
Myeloblasts 0.4 1.6
Promyelocytes 5.6 3.6
Neutrophil myelocytes 11.2 9.2
" juveniles • 10.8 10.8
M staffs 9.2 11.6
" segmented 7.6 14.4
Eosinophil myelocytes - -
M segmented - -
Basophil myelocytes - 0 .4
" segmented - -
lymphocytes 4.4 6 .4
Monocytes 2.4 1.6
Plasma cells 1.2 0.8
Pronormoblasts 0.8 0.8
Normoblasts
Basophilic 24.0 5.2
Polyc hromat ic 20.8 30.4
Orthochromatic 1.6’ 3.2
Mitotic forms 1.6 -
Maturity Dispersal Ratios 
Granuloblast 
Myeloblasts 1.5 6.3
Promyelocytes 20.0 34.0
Myelocytes 40.0 37.5
Juveniles 38.5 42.2
Erythroblast
Pronormoblast 1.6 2.0
Normoblast - basophilic 49.2 13. 1
polychromatic and \
orthochromatic ) 49.2 84.9
3E 
Table X
Case 10. Female, aged 72 years. Arteriosclerotic and mildly 
demented. Petechial haemorrhages on legs, ecchymoses on legs 
and thighs, effusion in left knee, brawny swelling of left calf, 
red cells in urine.
Treatment:- One thousand milligrammes ascorbic acid intravenous­
ly on 23.vii, and three hundred milligrammes daily by mouth from 
23*vii.
Date 22.vii 16.viii
ASCORBIC ACID DETERMINATIONS
Rotter*s Tgst (time, minutes) 20 8
Plasma ascorbic acid (mgms.
per cent) 0.45 1.8
CAPILLARY FRAGILITY 85 14
BLOOD EXAMINATIONS
Haemoglobin ('yo) 82 102
Colour Index 1.08 1.02
White cell count ( /cu*mm.)
*:
4,200 4,800
Schilling Count
Basophils - 0.25
Eosinophils 0.25 -
Myelocytes - -
Juveniles 0.25 1.5
Staffs 1.5 3.0
Segmented Neutrophils 47.5 47.25
Lymphocytes 41.5 39.25
Monocytes 9.0 8.75
Cooke Count - weighted mean 3.4 3.0
Platelet Count ( /cu.nm. ) 350,000
Table X  (contd.)
Date , 22.vii 16. viii
. BONE MARROW
»
Cellularity
Differential Count
Myeloblasts 0 .4 1.6
Promyelocytes 4.0 3.6
Neutrophil myelocytes 11.6 7.2
” juveniles 9.6 11.6
11 staffs 8.0 14.0
w segmented 7.6 18.0
Eosinophil myelocytes - 1.2
" segmented 0.4 -
Basophil myelocytes - 0.8
” segmented - 0.8
Lymphocytes 5.2 3 .2 ;
Monocytes 2.4 0.4
Plasma cells 1.6 0.8
Pronormoblasts 2.0 0.8
Normoblasts
Basophilic 16.8 5.2
Polychromatic 28.8 29.2
Orthochromatic
V
1.6 1.6
Mitotic forms 0.8
Maturity Dispersal Ratios
Granuloblast
Myeloblasts 1.6 6.2
Promyelocytes 15.6 13.8 1
Myelocytes 45.3 35.4
Juveniles 37.5 44.6
Erythroblast
Pronormoblast 4.0 2.2
Normoblast - basophilic 33.6 14.1
polychromatic prnd )
orthochromatic ) 62.4 83.7
Table X5
Oase 11. Male aged 51 years, with signs of scurvy - follicular 
haemorrhages and ecchymose3 on legs and thighs, red cells in 
urine, spongy gums, slight oedema of ankles.
Treatment:- One thousand milligrammes ascorbic acid intraven­
ously on 5*viii, and three hundred milligrammes ascorbic acid 
daily by mouth, from 5,viii.
Date l.viii 4.viii 7. viii
ASCORBIC ACID DETERMINATIONS
Rotter’s Test (time, minutes) 25
Plasma ascorbic acid (mgms,
per cent.) 0.41 0.43
CAPILLARY FRAGILITY 55 49
BLOOD EXAMINATIONS
Haemoglobin (%) 82 83 93
Colour Index 1.28 1.22
White cell count ( /cu.mm.) 4,800 4,600
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
Lymphocytes
Monocytes
1.25
0.5
0.25
0.25
69.75
24.5
3.5
1.75
1.0
3.5
55.0
34.5
4.25
Cooke Count - weighted mean 3.1 2.6
Platelet Count ( /cu.mm.) 450,000
Table S  (contd.)
Date 14* viii 21.viii
ASCORBIC ACID DETERMINATIONS
Rotter’s Test (time, minutes) 4
Plasma ascorbic acid (mgms.
per cent.) 1.6
CAPILLARY FRAGILITY 4
BLOOD EXAMINATIONS
Haemoglobin (fo) 96 96
Colour Index 1.19 1.19
White cell count ( /cu.mm.) 6,400 6,600
Schilling Count
Basophils 0.75 1.5
'Eosinophils - 0.25
Myelocytes - -
Juveniles^ 1.25 1.0
Staffs; 5.0 5.25
Segmented Neutrophils 47.75 71.25
Lymphocytes 42.0 : 17.0
Monocytes 3.25 3.75
Cooke Count - weighted mean 2.3 2.6
XXIV
Table XL (contd.)
Date I.viii 4.viii 7.viii
BONE MARROW
i
Cellularity
Differential Count
Myeloblasts 2.8 4.0 1.2
Promyelocyt es 4.8 5.6 4.0
Neutrophil myelocytes 3.2 4.0 5.6
” juveniles 3.6- 3.6 7.6
” staffs 7*2 2.0 2.0
M segmented 4.0 3.2 4.4
Eosinophil myelocytes 0.8 0.4 0.8
n segmented 0.8 0.8 0.8
Basophil nyelocytes 0.8 - 0.4
M segmented - - -
Lymphocytes 3.2 3.6 6.2
Monocytes 0.8 1.6 2.4
Plasma Cells 0.4 0.8 0.4
Pronormoblast s 3.2 2.4 2.8
Normoblasts
Basophilic 24.8 32.8 29.4
Polychromatic 39.6 32.4 31.6
Orthochromatic - 2.8 0.4
Mitotic forms 0.4 1.2 1.2
Maturity Dispersal Ratios.
Granuloblast
Myeloblasts 17.5 22.7 6.1
Promyelocytes 30.0 31.8 20.2
Myelocytes 30.0 25.0 34.8
Juveniles 22.5 20.5 38.9
Erythroblast
Pronormoblast 4.7 3.4 4.3
Normoblast - basophilic 36.7 45.8 46.0
'* polychromatic and
ort hoc hromat ic 58.6 50.8 49.7
XXV
Table XI (contd.)
>
Date 14.viii 21.viii
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 1.2 2.0
Promyelocytes 3.6 4.4
Neutrophil myelocytes 5.6 8.0
M juveniles 9.2 8.8
" staffs 5.2 11.2
" segmented 16.8 16.6
Eosinophil myelocytes 0.4 0.4
" segmented 0.4 -
Basophil myelocytes - 0.4
11 segmented - 0.4
lymphocytes 6.4 7.4
Monocytes 2.4 0.8
Plasma cells 0.4 0.7
Pronormoblasts !.2 -
Normoblasts
Basophilic 13.2 7.6
Polychromat ic 21.6 29.0
Orthochromatic 2.4 2.0
Mitotic forms 2.0 -
Maturity Dispersal Ratios. 
Granuloblast
Myeloblasts 6.0 7.6
Promyelocytes 18.0 18.8
Myelocytes 30 .0 36.8
Juveniles 46 .0 36.8
Erythroblast
Pro normoblas t 3.0 -
Normoblast - basophilic 33.0 19.8
polychromatic and
orthochromat ic
_________  . . _ L
64.0 80.2
xxvi
Table X U
Case 12. Male aged 55 years, with signs of scurvy - follicular 
haemorrhages on legs and thighs, ecchymosis over and indurated 
swelling in left calf, red cells in urine, spongy gums, moist 
sounds at lung bases, slight oedema of ankles.
TreatmentOne thousand milligrammes ascorbic acid intraven­
ously on 25#ii and three hundred milligrammes ascorbic acid 
daily from 26.ii
Date 25. ii 29. ii
ASCORBIC ACID DETERMINATIONS
Rotter's Tfist (time, minutes) 35
Plasma ascorbic acid (mgms.
per cent.) 0.37
CAPILLARY FRAGILITY 62
BLOOD EXAMINATIONS
Haemoglobin (%) 45 52
Colour Index o.Jg- 1.0
White cell count ( /eu.mm.) 5,200 6,000
Schilling Count
Basophils 0.25 -
Eosinophils - -
Myelocytes - -
Juveniles 0.5 -
Staffs 1.25 2.0
Segmented Neutrophils 28.0 23.8
Lymphocytes 59.0 61.4
Monocytes 11.0 12.8
Cooke Count - weighted mean 3.6 3.2
Platelet Count ( /cu.mm.) 500,000
XXVII
Table X U  (contd.)
Date 4.iii 15* iv
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 5 6
Plasma ascorbic acid (mgms.
per cent.) 1.4
CAPILLAR! FRAGILITY* 2 3
BLOOD EXAMINATIONS
Haemoglobin (%) 60 105
Colour Index 1.03 1.04
White cell count ( /cu.mm.) 5,200 5,400
Schilling Count
Basophils - 2.75
Eosinophils - -
Myelocytes - -
Juveniles 2.0 0.5
Staffs 4.25 3.5
Segmented Neutrophils 50.5 51.75
Lymphocytes 32.75 31.5
Monocytes 10.5 10.0
Cooke Count - weighted mean 2.8 2.6
XXVIU
Table XE (contd.)
Date 25. ii 29. ii
BONE MARROW >
Gellularity 
Differential Count
Myeloblasts 1.2 1.6
Promyelocytes 5.2 5.2
Neutrophil myelocytes 8.4 7.6
n juveniles 8.4 8.4
M staffs 4.8 4.4
" segmented 6.0 6.4
Eosinophil myelocytes 0.4 0.4
tt segmented - 0.8
Basophil myelocytes 0.8 0.4
" segmented - -
Lymphocytes 5.2 5.0
Monocytes 2.4 1.6
Plasma cells 1.2 1.2
Pronormoblast s 1.2 1.2
Normoblasts
Basophilic 35.2 34.0
Polyc hromat ic 16.0 17.6
Orthochromatic 3.6 4.0
Mitotic forms 1.2 1.6
Maturity Dispersal Ratios
Granuloblast
Myeloblasts 4.9 6.8
Promyelocytes 21.3 22.0
Myelocytes 34.4 35.6
Juveniles 39.4 35.6
Erythroblast
Pronormoblast 2.1 2.1
Normoblast - basophilic 61.5 58.2
n polychromatic and
36.4orthochromatic 39.7
XXIX
Table B E  ’ (contd.)
Date 4. iii 15. iv
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 1.2 0.4
Pronyelocytes 5.6 2.0
Neutrophil myelocytes 10.8 9.2
1 juveniles 12.8 10.0
" staffs 6.4 9.2
" segmented 6.8 9.6
Eosinophil myelocytes - 0.4
" segmented - 0.4
Basophil nyelocytes - 1.2
" segmented - 0.8
Lymphocytes 7.6 5.6
Monocytes 4.0 2.4
Plasma cells 2.0 0.4
Pronormoblasts 1.6 1.2
Normoblasts
Basophilic 26.4 9.6
Polychromat ic 12.4 36.0
Orthochromatic 4.4 1.6
Mitotic forms 2.0 0.8
Maturity Dispersal Radios 
Granuloblast
Myeloblasts 3*9 1.7
Promyelocytes 18.4 8.6
Myelocytes 43.1 43.1
Juveniles 34.6 46.6
Erythroblast
Pronormoblas t 3.4 2.4
Normoblast - basophilic 56.4 19.5
” polychromatic and
ort hoc hromat ic 40.2 78.1
Table XEE
Case 13* Male, aged 58 years, with signs of scurvy - follicular 
haemorrhages on legs, sponginess of gums, red cells in urine. 
Treatment:- One thousand milligrammes ascorbic acid intraven­
ously on 14.iv and three hundred milligrammes ascorbic acid 
d&ily by mouth from 14# iv.
Date 5.i* 9.iv 14. iv
ASCORBIC ACID DETERMINATIONS
Rotter's Test Ttime, minutes) 25
Plasma ascorbic acid (moms*
per cent) 0.41 0.38
CAPILLARY FRAGILITY 65 60
BLOOD EXAMINATIONS
Haemoglobin (%) 52 52 53
Colour Index
White Cell count ( /cuuran.)
1.0 6 
6,000
1.04 1.02
Schilling Count
0.8Basophils - *•
Eosinophils - - -
Myelocytes - - -
' Juveniles - 0.25 0.75
Staffs 1.2 2.75 1.5
Segmented Neutrophils 36. 4 37.25 41.25
lymphocytes 56.0 52.0 50.0
Monocytes 5.6 7.75 6.5
Cooke Count - weighted mean. 
Platelet Count ( /cu.mm.)
3.2
400,000
3.0 3.1
XXXl
Table ML (contd.)
Date
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 12 10
Plasma ascorbic acid (mgms.
per cent) 0.60 1.5
CAPILLARY FRAGILITY 8 8
BLOOD EXAMINATIONS
Haemoglobin (%) 99 100
Colour Index 1.1 1.06
White cell count ( /cu.mra.) 5,400 6,600
Schilling Count
Basophils - 0.4
Eosinophils 2.0 0.4
Myelocytes - -
Juveniles 2.0 0.4
Staffs 10.0 4.6
Segmented Neutrophils 45.6 48.6
lymphocytes 36.4 38.4
Monocytes 5.2 7.2
Cooke Count - weighted mean 2.7 2.8
Platelet Count ( /cu.snu)
4.V 20.v 30.T
XsXXU
Table XVU (contd.)
Date 5*iv 4.v 30. v
BONE MARROW
Cellularity
Differential Count
Myeloblasts 0.8 0.4 0.4
Promyelocytes 4.0 2.8 2.4
Neutrophil myelocytes 6.0 6.8 4.4
" juveniles 6.4 11.2 8.8
n staffs 6.0 6.8 2.0
" -segmented 8.4 6.4 12.4
Eosinophil myelocytes 0.4 0.4 0.4
" segmented 0.8 0.4 0.4
Basophil myelocytes 0.4 0.4 0.4
" segmented - 0.4 0.8
lymphocytes 6.4 4.0 4.4
Monocytes 3.2 0.8 2.0
Plasma cells 2.0 2.0 0.8
Pronormoblasts 0.8 1.6 0.4
Normoblasts
Basophilic 26.0 13.6 6.4
Polychromatic 26.0 40.0 39.6
Orthochromatic 2.4 2.0 4.0
Mitotic forms 1.6 2.0 0.4
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 4.4 1.8 2.4
Promyelocytes 22.4 12.7 34.2
Myelocytes 37.8 34.5 30.9
Juveniles 35.4 51.0 52.4
Erythroblast
Pronormoblast 1.4 2.7 0.8
Nomoblast - basophilic 45.8 23.0 12.6
polychromat- ) 
ic and ortho- )
chromatic ) 52.8 74.3 86.6
Table m
Case 14* Female, aged 60 years* No sign of scurvy* No 
physical abnormality noted other than marked pallor, and moist 
sounds at lung bases*
Treatment:- Ferrous sulphate, gr* vi t.i.d., from 17*i to l*ii 
and from 7*111 to 3.iv; ascorbic acid, one thousand milligrammes 
intravenously on 26. i, and three hundred milligrammes daily by 
mouth from 26.i, "Anahaemin", 4 c*c* intramuscularly on 14#ii; 
and four oranges daily from 22»iii
Date 17. i 26. i 26* ii
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 25
Plasma ascorbic Acid (moms*
per cent) 0.4
CAPILLARY FRAGILITY 40 48
BLOOD EXAMINATIONS
Haemoglobin (%) 53 53 55
Colour Index 0.8 0.85 0.79
White cell count ( /cu.ram*) 4*600 6,000 5,400
Schilling Count 
Basophils 
Eosinophils 
Igrelocytes 
Juveniles 
Staffs
Segmented Neutrophils
lymphocytes
Monocytes
0.5
0.25
2.25
46.0
41.0
10.0
0.5
1.0
1.25
35.25
48.5
9.5
1.0
2.75
36.5 
46.25
13.5
Cooke Count - weighted mean 3.2 3.2 2.8
Platelet Count ( /cu.mm*) 350,000
xxxW
Table XiV (contd.)
Date 28. ii 8.iii 14*iii
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 12 5
Plasma ascorbic acid (mgms.
per cent) 0.7
CAPILLAR? FRAGILITY 30 8 10
BLOOD EXAMINATIONS
Haemoglobin (%) 55 55 57
Colour Index 0.79 0.85 0.85
White cell count ( /cu.hjqO 5,600 5,400
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
lymphocytes
Monocytes
°45
0.25
2.75
3.0 
43.75 
41.25
8.0
1.0
mm
1.25
38.5
40.0
15.0
Cooke Count - weighted mean 2.4 . 2.1
XXXV
Table XIV (contd*)
Date 27* iii 3.iT
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 5
Plasma asoorbio acid (moms.
per cent.)
CAPILLAR! FRAGILITY 7
BLOOD EXAMINATIONS
Haemoglobin (%) 72 81
Colour Index 0.95 0.99
White cell count ( /otumnu) 5,400 6,000
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
lymphocytes
Monocytes
m
1.25
2.5
47.25
40.25 
8.75
Cooke Count - weighted mean 2.1
Platelet Count ( /cu*mm*) 400,000
x x x v  I
Table 12?" (oo'ntd.)
Date 16. i 8.iii 3.iv
BONE MARROW
Cellularity
Differential Count 
ifyeloblasts 3.2 1.6 2.0
Promyelocytes 3.6 3.6 4.0
Neutrophil myelocytes 4.8 9.2 9.6
" Juveniles 5.6 8.6 11.4
w staffs 34.0 18.8 14.0
n segmented 17.2 13.2 34.4
Eosinophil myelocytes - . - -
" segmented - - -
Basophil myelocytes 0.4 0.8 0.4
", segmented - - -
lymphocytes 4.0 5.2 5.6
Monocytes 2.4 2.4 2.8
Plasma cells 1.6 1.6 1.2
Pronormoblasts 2.8 1.6 2.0
Normoblasts
Basophilic 19.2 5.2 4.0
Polychromatic 15.6 27.8 25.0
Orthochromatic 5.6 0.4 3.6
Mitotio forms 0.4 - 0.4
Maturity Dispersal Ratios 
Granuloblast 
Ifyeloblasts 18,2 6.7 6*6
Promyelocytes 20.4 15.1 13.1
Myelocytes 29.6 42.0 32.9
Juveniles 31.8 36.0 47.4
Erythroblast
Pronormoblast 6.4 4.6 5.7
Normoblast - basophilic *4.1 32.0 11.4
polychromat* ) 
ic and ortho- ) 
chromatic ) 49.5 63.4 82.9
xxxvn
Table W
Case 15* Male, aged 78 years. No sign of scurvy. Bedridden, 
mildly demented, arteriosclerotic.
Treatment:- One thousand milligrammes ascorbic acid intraven­
ously on 25. v, and three hundred milligrammes daily by mouth 
from 25. v; four oranges daily from 17* vi
Date 25.v 29.v
ASCORBIC ACID DETERMINATIONS
Hotter*s Test (time, minutes) 20 18
Plasma ascorbic acid (msms.
per oent) 0.4 0.43
CAPILLARY FRAGILITY 56 59
BLOOD EXAMINATIONS
Haemoglobin (%) 60 60
Colour Index 1*58 1.58
White cell count ( /ciunm.) 2,400 2,200
Schilling Count
Basophils - 1.25
Eosinophils mm -
Myelocytes - mm
Juveniles 0.5 0.5
Staffs 1.25 1.75
Segmented Neutrophils 49.75 50.75
lymphocytes 41.5 30.0
Monocytes 7.0 5.25
Cooke Count - weighted mean 3.2 3.4
Platelet Count ( /cu.n*n.) 650,000
X X  XV U l
Table 2 T  (contd.)
\ V-
Date 17.vi 18.viii
ASCORBIC ACID DETERMINATIONS
Rotter's Test (tine, minutes) 14 6
Plasma ascorbic acid (mem.
per cent*) 1.5
CAFILEAHI FRAGILITY 50 8
BLOOD EXAMINATIONS
Haemoglobin (%) 61 88
Colour Index 1.49 1.3
White cell count ( /outran.) 2,900 4,400
Schilling Count
BasopkLls 2.0 2.5
Eosinophils 0.5 0.75
Myelocytes - -
Juveniles • 0.25
Staffs 2.5 3.0
Segmented Neutrophils 50.0 57.0
lymphocytes 40.0 33.25
Monocytes 5*0 3.25
Cooke Count - weighted mean 3.2 2.8
XKXtX
Table 33. (contd.)
Date 25.v 31. ▼
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 2.8 0.3
Promyelocytes 6.8 4.6
Neutrophil myelocytes 11.2 12.5
" Juveniles 6.4 11.0
" staffs 4*8 5.0
" segmented 6.0 5.0
Eosinophil myelocytes - mm
H segmented - 0.6
Basophil myelocytes 2.0 1.3
” segmented 2.0 1.6
lymphocytes 0.8 2.0
Monocytes - 3.4
Plasma cells 1.2 1.0
Pronormoblasts 1.6 1.3
Normoblasts
Basophilic 25.2 21.6
Polychromatic 26.4 25.0
Orthochromatic 2.8 4.0
Mitotic forms 1.6 . 3.0
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 9.6 1.0
Promyelocytes 23.1 15.6
Myelocytes 45.0 46.1
Juveniles 21.9 37.2
Erythroblast
Pronormoblast 2.9 2.4
Normoblast - basophilic 45.0 37.5
polychromatic
and corthochromatic 52.1 56.3
Table XY (contd.)
Date 18. vi 18.viii
BOND MARROW 
Cellularity1 
Differential Count ,
Myeloblasts 0.4 0.4
Promyelocytes 4.0 5.2
Neutrophil myelocytes 7.2 11.2
" juveniles 9.2 12.4
" staffs 9.6 8.0
n  segmented 8.0 6.4
Eosinophil myelocytes 1.2 -
" segmented - -
Basophil myelocytes - 0.4
n segmented - 1.2
Lymphocytes 6.4 5.2
Monocytes 3.2 0.4
Plasma cells 3.6 1.2
Pronormoblasts 0.8 1.6
Normoblasts
Basophilic 15.2 15.2
Polychromatic 26.8 26.8
Orthochromatic 4*4 4.4
Mitotic forms 1.2 0.4
Maturity Dispersal Ratios 
Granuloblast
Myeloblast 1.9 1.4
Promyelocytes 18.9 17.6
Myelocytes 38.2 39.2
Juveniles 42.0 41.8
Erythroblast
Pronormoblast 1.5 3.3
Normoblast - basophilic 35.6 31.4
polychromatic
63.0 65.3and orthochromatic
Table "EZL
Case 16. Hale, aged 71 years, with signs of scurvy - follicular 
haemorrhages and ecohymoses on legs, red cells in urine, oedema 
of ankles and legs, moist sounds at lung bases.
Treatment:- One thousand milligrammes ascorbic acid intravenous­
ly on 20. v, and three hundred milligrammes daily by mouth from 
20. v; four oranges daily from 23.vi
Date 21.v 27 .▼ 31.v
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 20
Plasma ascorbic acid (mgms.
per oent)
CAPILLARY FRAGILITY
0.45
58
0.43
BLOOD EXAMINATIONS
Haemoglobin ( % ) 68 69 65
Colour Index 0.9 0.96 0.9
White cell count ( /cu.mn.) 4,000 8,200 5,400
Schilling Count
Basophils 1.5 1.0
Eosinophils 0.5 0,5 -  .
Ifyelocytes - mm -
Juveniles 0.5 0.5 0.5
Staffs 1.5 1.0 2.0
Segmented Neutrophils 57.0 51.0 46.0
lymphocytes 34.0 40.5 41.5
Monocytes 5.0 6.0 9.0
Cooke Count - weighted mean 
Platelet Count ( /cu.mu )
3.5
300,000
3.3 3.4
Sable £4. (oontd.)
Date 17.*L 22. vi
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 15
Plasma ascorbic aoid (mgms*
per cent*)
CAPILLARY FRAGILITY 51
BLOOD EXAMINATIONS
Haemoglobin (%) 68 67
Colour Index 0.97 1.0
White eell count ( /cu*job*) 5,000 4,400
Schilling Count
Basophils 1.0 0.75
Eosinophils 0.25 1.75
Myelocytes - -
Juveniles 0.25 0.5
Staffs 2.75 3.0
Segmented Neutrophils 41.25 49.5
lymphocytes 47.75 37.0
Monocytes 7.75 7.5
Cooke Count - weighted mean 3.4 3.2
ftable &11 (oontd.)
Date 30. vi 20.vlii
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 5
Plasma ascorbic acid (mams.
per cent. ) 0.7 1.4
CAPILLARY FRAGILITY 50 11
BLOOD EXAMINATIONS
Haemoglobin ( % ) 70 88
Colour Index 0.99 0.98
White cell count ( , /eu.snu) 5,200 5,600
Schilling Count
Basophils 0.75 0.75
Eosinophils 0.75 1.75
Myelocytes • - -
Juveniles 0.25 1.25
Staffs 3.75 4.0
Segmented Neutrophils 48.5 50.25
lymphocytes 38.75 35.5
Monocytes 8.25 6.5
Cooke Count - weighted mean 3.1 2.6
Tata* }SE (oontd.)
Date 21.V 27.v
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 0.8 0.4
Promyelocytes 5.2 4.4
Neutrophil myelocytes 12.8 13.8
" Juveniles 14.4 13.2
** staffs 5.2 8.0
N segmented 17.2 17.2
Eosinophil myelocytes - -
tt segmented 1.2 0.4
Basophil myelocytes 0.4 0.4
* segmented 0.4 1.6
lymphocytes 8.0 6.8
Monocytes 2.4 0.8
Plasma cells 1.2 1.6
Pronormoblasts 0.8
Normoblasts
Basophilic 8.4 6.4
Polychromatic 20.4 24.8
Orthochromat ic 1.2 0.4
Mitotic forms - 0.4
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 2.4 1.3
Promyelocytes 15.5 13.7
Myelocytes 39.1 43.7
Juveniles 4-3.0 41.3
Erythroblast
2.6Pronormoblast
Normoblast - basophilic 27.3 20.0
polychromatic )
and orthochromatic) 70.1 80.0
[Table 521 (contd. )
Date
I 31* ▼ 17. vi 20.viii
BONE MARROW 
Cellularity 
Differential Count
l^ reloblasts 0.4 - 0.8
Promyelocytes 4.4 4.4 4.0
Neutrophil myelocytes 14.8 9.2 8.0
** juveniles 14.0 34.8 10.4
" staffs 6.0 5.6 16.0
" segmented 12.0 15.2 18.0
Eosinophil myelocytes 0.4 - -
" segmented 0.4 0.8 -
Basophil myelocytes 0.8 0.4 0.4
n segmented - 1.2 -
lymphocytes 6.4 8.0 7.6
Monocytes 0.4 1.2 1.2
Plasma cells 0.8 0.8 1.6
Pronormoblasts - 0.8 0.8
Normoblasts
Basophilic 10.0 8.0 3.6
Polychromatic 27.6 28.4 26.0
Orthochromatic 2.0 1.2 1.6
Mitotic forms - 0.4 -
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 1.2 - 3.4
Promyelocytes 12.8 15.2 16.9
Myelocytes 43.3 33.4 35.6
Juveniles 40.7 51.4 i»4.1
Erythroblast
Pronormoblast - 2.1 2.5
Nonnoblast - basophilic 25.3 20.6 11.2
polychromatic and)
86.5orthochromatic ) 74.7 77.3
Table M
Case 17* Female aged 43 years, with signs of scurvy - follicul­
ar haemorrhages on legs, extensive eochymosis on legs and thighs, 
red cells in urine, sponginess of gums, racist sounds at lung 
bases.
Treatment:- Hespiridin, forty milligrammes intravenously daily 
from 7*ix to 14. ix and from 21,ix to 6,k; ascorbic acid, one 
thousand milligrammes intravenously on 14* ix, and three hundred 
milligrammes daily by mouth from 14. ix.
Date
ASCORBIC ACID DETERMINATIONS
Rotter*s Test (time, minutes)
Plasma ascorbio acid (ragm3.
per cent.)
CAPILLAR! FRAGILITY 
BLOOD EXAMINATIONS 
Haemoglobin ( % )
Colour Index
White oell count ( /cu.mm.)
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
lymphocytes
Monocytes
Cooke Count - weighted mean
Platelet Count ( /cu.mm.)
I.ix 7*ix lO.ix
35
0.4
45 53
53 4^ 41
0.95 1.01 1.1
7,400 6,800 2,800
1.5 3.5
0.75 -
- 0.25
- 2.25
- 3.75
50.5 56.0
38.25 24.5
9.0 9.75
3.3 2.9
600,00C
vlv’ii
Table 3331 (oontd. )
Date 12. ix 14. ix 17. ix
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes') 38
Plasma ascorbic acid (moms*
per cent.) 0.35
CAFILIARY FRAGILITY 3
BLOOD EXAMINATIONS
Haemoglobin (%) 43 40 46
Colour Index 1.0 1.06 1.08
White cell count ( /cu.nm.) 2,600 3,800 2,600
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils 
lymphocytes 
Monocytes'
1.75 
0.25 
0.25
1.75
2.75 
44.0 
36.75 
13.5
0.75
2.0
1.0
0.75
33.5
45.25
16.75
2.25 
0.25
1.25
2.5 
48.75 
31.25
9.5
Cooke Count - weighted mean 2.8 2.7 2.8
Table ^ N\L (oontd.)
t
Date 21. ix 23. ix 17.x
ASCORBIC ACID DETERMINATIONS
Rotter*s Test (time, minutes) 6
Plasma ascorbic acid (mgmd.
per cent*) 1.6
CAPXLLAHT FRAGILITT 15 2
BLOOD EXAMINATIONS
Haemoglobin ( % ) 37 48 86
Colour Index 1.0 0.99 0.92
White cell count ( /cu.nm.) 4,000 4,200 5,000
Schilling Count 
Basophils 
Eosinophils 
Myelocytes 
Juveniles 
Staffs
Segmented Neutrophils
lymphocytes
Monocytes
0.5
0.25
3.25
2.5 
43.75 
40.25
4.5
2.0
1.5
1.0
1.5 
49.5 
40.0
4.5
Cooke Count - weighted mean 2.7 2.7
Table "3SE. (oontd. )
Date l.ix 17. ix
BONE MARROW
Gellularity
Differential Count 
Myeloblasts 0.4 0.4
Promyelocytes 10.8 6.8
Neutrophil myelocytes 13.2 13.2
M juveniles 12.0 12.8
H staffs 3.2 3.6
tt segmented 4.0 6.4
Eosinophil myelocytes 0.8 0.8
" segmented 2.8 0.4
Basophil myelocytes 0.4 -
n segmented - •
lymphocytes 5.6 1.2
Monocytes 1.2 0.4
Plasma cells 1.2 1.2
Pronormoblasts 1.2 0.8
Normoblasts *
Basophilic 22.0 28.0
Polychromatic 21.2 24.0
Orthochromatic - -
Mitotic forms 0.8 0.4
Maturity Dispersal Ratios
Granuloblast
Myeloblast 1.1 1.2
Promyelocytes 28.8 20.0
Myelocytes 38.2 41.2
Juveniles 31.9 37.6
Erythroblast
Pronormoblast 2.7 1.5
Normoblast - basophilic 48.9 52.6
polychromatic and 
orthochromatic 48.4 45.9
13fable (contd.)
Date 23. ix 29. ix
BONE MARROW 
Cellularity 
Differential Count
Myeloblasts 1.2 0.4
Promyelocytes 4.0 9.2
Neutrophil myelocytes 9.6 10.0
" juveniles 10.8 12.0
■" staffs 6.0 15.2
N segmented 5.2 10.0
Eosinophil myelocytes 0.4 0.4
" segmented 0.8
Basophil myelocytes - 1.6
” segmented - 1.6
lymphocytes 5.2 2.8
Monocytes 2.0 0.8
Plasma cells 0.4 0.8
Pronormoblasts 0.4 0.4
Normoblasts
Basophilic 11.2 6.0
Polychromatic 55.6 50.0
Orthochromatic 7.2 0.8
Mitotic forms - 0.4
Maturity Dispersal Ratios 
Granuloblast
4.6Myeloblasts 1.2
Promyelocytes 15.4 27.6
Myelocytes 58.4 55.0
Juveniles 41.6 56.2
Erythroblast
Pronormoblast 0.7 1.1
Normoblast - basophilic 20.6 16.0
polychromatic and )
orthochromatic ) 78.9 82.9
Table XV iff
Two oases of scurvy associated with rheumatoid arthritis. 
Effects of antiscorbutic treatment not recorded
Case 18 19
ASCORBIC ACID DETERMINATIONS
Rotter's Test (time, minutes) 35 23
Plasma ascorbic acid (moms.
per cent.) 0.3 0.4
CAPILLARY FRAGILITY 55 62
BLOOD EXAMINATIONS
Haemoglobin ( % ) 65 60
Colour Index 0.9 1.05
White cell count ( /cu.ranu) 5,600 7,200
Schilling Count
Basophils - -
Eosinophils 0.25 -
Myelocytes - -
Juveniles 0.5 0.4
Staffs 1.5 1.8
Segmented neutrophils 55.0 41.0
lymphocytes 35.0 48.2
Monocytes 7.75 8.6
Cooke Count - weighted mean 3.4 3.2
Platelet Count ( /cu.imu) 450,000 >40,000
Table ys/ljL (contd.)
Case 18 19
BONE MARROW 
Cellularity
Differential Count
Myeloblasts 1.6 0.8
Promyelocytes 3.6 4.0
Neutrophil myelocytes 6.0 6.0
w juveniles 8.4 8.8
n staffs 14.0 12.4
" segmented 16.4 18.4
Eosinophil myelocytes - -
w segmented 0.8 -
Basophil myelocytes - 0.8
” segmented 0.8 -
lymphocytes 7.2 6.4
Monocytes 2.4 3.6
Plasma cells 0.8 0.8 1
Pronormoblasts 3.2 2.8 j
Normoblasts
Basophilic 19.2 7.6
Polychromatic H.2 23.2 |
Orthochromatic 2.8 4.4
Mitotic forms 1.6 2.0
Maturity Dispersal Ratios 
Granuloblast
Myeloblasts 8.2 3.9
Promyelocytes 18.6 19.6
Myelocytes 30.6 33.3
Juveniles 42.6 43.2
Erythroblast
8.4Pronormoblast 7.5
Normoblast - basophilic 53.6 19.7
polychromatic and )
orthochromatic ) 38.0 72.8
Table XIX (contd.)
)
Two cases of scurvy associated with duodenal ulceration, 
with history of haematemeses and melaena.
Effects of antiscorbutic treatment not recorded.
Case 20 21
ASCORBIC ACID DETERMINATIONS
Hotter*s Test (time, minutes) 30 25
Plasma asoorbic acid (moms.
per cent.) 0.3 0.35
CAPILLAR! FRAGILITY 5 9
BLOOD EXAMINATIONS
Haemoglobin ( % ) 50 62
Colour Index 0.75 0.8
' White cell count ( /cu.nm.) 8,400 7,600
Schilling Count
Basophils - -
Eosinophils 0.5 -
Myelocytes - -
Juveniles 0.5 -
Staffs 1.75 1.75
Segmented neutrophils 31.25 40.0
lymphocytes 46.0 50.75
Monocytes 10.0 7.25
Cooke Count - weighted mean 3.0 3.1
Platelet Count ( /cu.ma.) 350,000 580,000
l i v
Table VIXL (contd*)
Case 20 21
BONE MARROW
Cellularity
Differential Count 
Myeloblasts 0.8
Promyelocytes 6.0 2.0
Neutrophil myelocytes 10.4 14.0
” juveniles 12.0 16.4
H staffs 9.6 10.4
n segmented 10.4 12.0
Eosinophil myelocytes - -
w segmented - -
Basophil myelocytes 1.6 -
" segmented - -
lymphocytes 6.4 8.8
Monocytes 3.2 1.6
Plasma cells 0.4 0.8
Pronormoblasts 2.0 1.2
Normoblasts
Basophilic 9.6 11.2
Polychromatic 18.0 20.0
Orthochromatic 9.6 1.6
Mitotic forms 1.2 1.6
Maturity Dispersal Ratios 
Granuloblast 
Myeloblasts 2.6
Promyelocytes 19.4 6.2
Myelocytes 39.0 43.2
Juveniles 39.0 50.6
Erythroblast
Pronormoblast 4.8 4.3
Normoblast - basophilic 24.3 32.5
polychromatic and ) 
orthochromatic ) 70.9 65.2
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Blood chart, case 7; showing-reticulocyte response, 
rise in red cells and haemoglobin, and tail in 
capillary fragility, on administration of ascorbic 
acid.
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JIGURE II.
Blood chart, case 8; showing reticulocyte 
response, rise in red cells and haemoglobin, 
and fall in capillary fragility, on 
administration of ascorbic acid.
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Blood chart, case 9; showing reticulocyte 
response, rise in red cells and haemoglobin, 
and fall in capillary fragility, en administration 
of ascorbic acid.
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Blood chart, case lu; showing reticulocyte 
response, rise in red cells and haemoglobin, 
and fall in capillary fragility, on administration 
of ascorbic acid.
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Blood chart, case 11; showing reticulocyte 
response, rise in red cells and haemoglobin, 
and tail in capillary fragility, on administration 
of ascorbic acid.
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Blood chart, case 12; showing reticulocyte response, rise 
in red cells and haemoglobin, and tail in capillary fragility, 
on administration of ascorbic acid.
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Blood, chart, case 13; showing reticulocyte response, rise in 
red cells and haemoglobin, and fall in capillary fragility, 
on administration ol ascorbic acid.
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Blood chart, case 14; showing response of capillary 
fragility to administration of oranges and lack: of 
response to ascorbic acid, ultimate response to iron 
with initial absence of such response associated with 
high capillary fragility (and low ascorbic acid values 
not shown here;.
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AscorW c^c»4 
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1’IGURE I X .
Blood chart, case 15; showing lack of reticulocyte response and
indeiinite response or red cells and haemoglobin to ascorbic acid 
alone; reticulocyte response and rise in red cells and haemoglobin 
following addition of oranges.
Lxw
A sco rb ic . a c % 4 . 5 o o  m ^ « s . 4 o il« | m o o i-li.
^MgtWK. aci<l 
tO OO an^mt. 4- Oranges daily
20
i? IG U B E  X .
Blood chart, case 16; showing lack; of reticulocyte 
response or rise in red cells and haemoglobin 
following administration of ascorbic acid alone; 
reticulocyte response and rise in red cells and 
haemoglobin following addition of oranges.
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Blood chart, case 17; showing reticulocyte response 
and rise in red cells and haemoglobin during the 
administration of hesperidin and ascorbic acid 
concurrently, with absence or such response to 
either when administered separately.
